false Q3 2022 0000913277 Yes Yes P12Y7M6D P12Y7M6D P7Y P13Y6M P10Y P13Y6M 2023-02-01 2023-02-01 2023-02-01 2023-02-01 P12Y10M24D P10Y P10Y2M12D P13Y9M18D P9Y4M24D P13Y P10Y P10Y2M12D P13Y9M18D P9Y4M24D 0000913277 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0000913277 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0000913277 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0000913277 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000913277 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000913277 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000913277 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000913277 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000913277 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000913277 us-gaap:TreasuryStockMember 2022-09-30 0000913277 us-gaap:RetainedEarningsMember 2022-09-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000913277 us-gaap:TreasuryStockMember 2022-06-30 0000913277 us-gaap:RetainedEarningsMember 2022-06-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000913277 2022-06-30 0000913277 us-gaap:TreasuryStockMember 2022-03-31 0000913277 us-gaap:RetainedEarningsMember 2022-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000913277 2022-03-31 0000913277 us-gaap:TreasuryStockMember 2021-12-31 0000913277 us-gaap:RetainedEarningsMember 2021-12-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000913277 us-gaap:TreasuryStockMember 2021-09-30 0000913277 us-gaap:RetainedEarningsMember 2021-09-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000913277 us-gaap:TreasuryStockMember 2021-06-30 0000913277 us-gaap:RetainedEarningsMember 2021-06-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000913277 2021-06-30 0000913277 us-gaap:TreasuryStockMember 2021-03-31 0000913277 us-gaap:RetainedEarningsMember 2021-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000913277 2021-03-31 0000913277 us-gaap:TreasuryStockMember 2020-12-31 0000913277 us-gaap:RetainedEarningsMember 2020-12-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000913277 us-gaap:CommonStockMember 2022-09-30 0000913277 us-gaap:CommonStockMember 2022-06-30 0000913277 us-gaap:CommonStockMember 2022-03-31 0000913277 us-gaap:CommonStockMember 2021-12-31 0000913277 us-gaap:CommonStockMember 2021-09-30 0000913277 us-gaap:CommonStockMember 2021-06-30 0000913277 us-gaap:CommonStockMember 2021-03-31 0000913277 us-gaap:CommonStockMember 2020-12-31 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestOverPeriodOfThreeYearsMember 2022-01-01 2022-09-30 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestInOneToThreeYearsMember 2022-01-01 2022-09-30 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember bde:FourEqualConsecutiveQuarterlyTranchesFromDateOfGrantMember 2022-01-01 2022-09-30 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-01-01 2022-09-30 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingImmediatelyMember 2022-01-01 2022-09-30 0000913277 us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember bde:VestingImmediatelyMember 2022-09-30 0000913277 srt:MinimumMember us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-09-30 0000913277 srt:MaximumMember us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-09-30 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-03-04 0000913277 us-gaap:RestrictedStockMember 2022-03-04 2022-03-04 0000913277 srt:MinimumMember us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-01-01 2022-09-30 0000913277 srt:MaximumMember us-gaap:EmployeeStockOptionMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-01-01 2022-09-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000913277 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000913277 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2022-07-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2022-07-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2022-07-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2022-07-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2022-07-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2022-07-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember 2022-07-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember 2022-07-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2022-01-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2022-01-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2022-01-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2022-01-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2022-01-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2022-01-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember 2022-01-01 2022-09-30 0000913277 bde:DomesticSalesRevenueMember 2022-01-01 2022-09-30 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2021-07-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2021-07-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2021-07-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2021-07-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2021-07-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2021-07-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember 2021-07-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember 2021-07-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember bde:PrecisionSportSegmentMember 2021-01-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember bde:OutdoorSegmentMember 2021-01-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember bde:AdventureSegmentMember 2021-01-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:PrecisionSportSegmentMember 2021-01-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:OutdoorSegmentMember 2021-01-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember bde:AdventureSegmentMember 2021-01-01 2021-09-30 0000913277 bde:InternationalSalesRevenueMember 2021-01-01 2021-09-30 0000913277 bde:DomesticSalesRevenueMember 2021-01-01 2021-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000913277 us-gaap:MachineryAndEquipmentMember 2022-09-30 0000913277 us-gaap:LandMember 2022-09-30 0000913277 us-gaap:FurnitureAndFixturesMember 2022-09-30 0000913277 us-gaap:ConstructionInProgressMember 2022-09-30 0000913277 us-gaap:BuildingAndBuildingImprovementsMember 2022-09-30 0000913277 bde:ComputerHardwareAndSoftwareMember 2022-09-30 0000913277 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000913277 us-gaap:LandMember 2021-12-31 0000913277 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000913277 us-gaap:ConstructionInProgressMember 2021-12-31 0000913277 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0000913277 bde:ComputerHardwareAndSoftwareMember 2021-12-31 0000913277 bde:MaxtraxMember 2022-07-01 2022-09-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000913277 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-07-01 2022-09-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-09-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000913277 bde:OperatingLossCarryforwardExpirationYear2025AndBeyondMember 2022-09-30 0000913277 bde:OperatingLossCarryforwardExpirationYear2024Member 2022-09-30 0000913277 bde:OperatingLossCarryforwardExpirationYear2023Member 2022-09-30 0000913277 bde:OperatingLossCarryforwardExpirationYear2022Member 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2022-07-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2022-07-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2022-07-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2022-01-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2022-01-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2022-01-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2021-07-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2021-07-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2021-07-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:PrecisionSportSegmentMember 2021-01-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:OutdoorSegmentMember 2021-01-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember bde:AdventureSegmentMember 2021-01-01 2021-09-30 0000913277 us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000913277 bde:TermFacilityMember 2022-09-30 0000913277 bde:TermFacilityMember 2021-12-31 0000913277 us-gaap:LetterOfCreditMember bde:RestatedCreditAgreementMember 2022-09-30 0000913277 srt:MinimumMember bde:ForeignCreditFacilityMember 2022-09-30 0000913277 srt:MaximumMember bde:ForeignCreditFacilityMember 2022-09-30 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2022-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2021-12-31 0000913277 srt:MinimumMember bde:ForeignCreditFacilityMember 2021-12-31 0000913277 srt:MaximumMember bde:ForeignCreditFacilityMember 2021-12-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2021-12-31 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2022-01-01 2022-09-30 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2022-01-01 2022-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2022-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember 2022-09-30 0000913277 bde:ForeignCreditFacilityMember 2022-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0000913277 bde:ForeignCreditFacilityMember 2021-12-31 0000913277 bde:SierraTrademarkMember 2022-09-30 0000913277 bde:RhinoRackTrademarkMember 2022-09-30 0000913277 bde:PiepsTrademarkMember 2022-09-30 0000913277 bde:MaxtraxTrademarkMember 2022-09-30 0000913277 bde:BlackDiamondTrademarkMember 2022-09-30 0000913277 bde:BarnesTrademarkMember 2022-09-30 0000913277 bde:SierraTrademarkMember 2021-12-31 0000913277 bde:RhinoRackTrademarkMember 2021-12-31 0000913277 bde:PiepsTrademarkMember 2021-12-31 0000913277 bde:MaxtraxTrademarkMember 2021-12-31 0000913277 bde:BlackDiamondTrademarkMember 2021-12-31 0000913277 bde:BarnesTrademarkMember 2021-12-31 0000913277 bde:RhinoRackMember us-gaap:TrademarksMember 2022-01-01 2022-09-30 0000913277 bde:MaxtraxMember us-gaap:TrademarksMember 2022-01-01 2022-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-07-01 2022-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000913277 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000913277 us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-09-30 0000913277 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000913277 bde:ProductTechnologiesMember 2022-01-01 2022-09-30 0000913277 bde:CoreTechnologiesMember 2022-01-01 2022-09-30 0000913277 us-gaap:TrademarksAndTradeNamesMember 2021-01-01 2021-12-31 0000913277 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000913277 bde:ProductTechnologiesMember 2021-01-01 2021-12-31 0000913277 bde:CoreTechnologiesMember 2021-01-01 2021-12-31 0000913277 2021-01-01 2021-12-31 0000913277 us-gaap:TrademarksAndTradeNamesMember 2022-09-30 0000913277 us-gaap:CustomerRelationshipsMember 2022-09-30 0000913277 bde:ProductTechnologiesMember 2022-09-30 0000913277 bde:CoreTechnologiesMember 2022-09-30 0000913277 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0000913277 us-gaap:CustomerRelationshipsMember 2021-12-31 0000913277 bde:ProductTechnologiesMember 2021-12-31 0000913277 bde:CoreTechnologiesMember 2021-12-31 0000913277 bde:RhinoRackMember 2021-12-31 0000913277 bde:MaxtraxMember 2021-12-31 0000913277 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000913277 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000913277 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000913277 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000913277 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000913277 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0000913277 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2022-07-01 2022-09-30 0000913277 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000913277 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-07-01 2021-09-30 0000913277 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000913277 currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000913277 currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000913277 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember bde:RestatedCreditAgreementMember 2022-01-01 2022-09-30 0000913277 us-gaap:RevolvingCreditFacilityMember bde:ForeignCreditFacilityMember 2022-01-01 2022-09-30 0000913277 bde:TermFacilityMember bde:ForeignCreditFacilityMember 2022-01-01 2022-09-30 0000913277 bde:RestatedCreditAgreementMember 2022-01-01 2022-09-30 0000913277 bde:TermFacilityMember bde:RestatedCreditAgreementMember 2022-01-01 2022-09-30 0000913277 us-gaap:SubsequentEventMember 2022-11-03 2022-11-03 0000913277 2022-04-01 2022-06-30 0000913277 2022-01-01 2022-03-31 0000913277 2021-04-01 2021-06-30 0000913277 2021-01-01 2021-03-31 0000913277 us-gaap:AccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2022-09-30 0000913277 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000913277 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000913277 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000913277 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000913277 2021-09-30 0000913277 2020-12-31 0000913277 bde:RhinoRackMember 2022-09-30 0000913277 bde:MaxtraxMember 2022-09-30 0000913277 srt:MinimumMember bde:ContingentConsiderationMember 2022-09-30 0000913277 srt:MaximumMember bde:ContingentConsiderationMember 2022-09-30 0000913277 bde:MaxtraxMember bde:ContingentConsiderationCommonStockMember 2021-12-01 0000913277 bde:MaxtraxMember bde:ContingentConsiderationCashMember 2021-12-01 0000913277 bde:MaxtraxMember bde:ContingentConsiderationCommonStockMember 2021-12-01 2021-12-01 0000913277 bde:MaxtraxMember bde:ContingentConsiderationCashMember 2021-12-01 2021-12-01 0000913277 2021-07-01 2021-07-01 0000913277 bde:MaxtraxMember bde:ContingentConsiderationCommonStockMember 2022-07-01 2022-09-30 0000913277 bde:MaxtraxMember 2021-12-01 2021-12-01 0000913277 bde:RhinoRackMember 2021-07-01 2021-07-01 0000913277 us-gaap:FairValueInputsLevel2Member 2022-09-30 0000913277 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000913277 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000913277 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000913277 us-gaap:CorporateMember 2022-09-30 0000913277 bde:PrecisionSportSegmentMember 2022-09-30 0000913277 bde:OutdoorSegmentMember 2022-09-30 0000913277 bde:AdventureSegmentMember 2022-09-30 0000913277 us-gaap:CorporateMember 2021-12-31 0000913277 bde:PrecisionSportSegmentMember 2021-12-31 0000913277 bde:OutdoorSegmentMember 2021-12-31 0000913277 bde:AdventureSegmentMember 2021-12-31 0000913277 bde:PrecisionSportSegmentMember 2022-07-01 2022-09-30 0000913277 bde:OutdoorSegmentMember 2022-07-01 2022-09-30 0000913277 bde:AdventureSegmentMember 2022-07-01 2022-09-30 0000913277 bde:PrecisionSportSegmentMember 2022-01-01 2022-09-30 0000913277 bde:OutdoorSegmentMember 2022-01-01 2022-09-30 0000913277 bde:PrecisionSportSegmentMember 2021-07-01 2021-09-30 0000913277 bde:OutdoorSegmentMember 2021-07-01 2021-09-30 0000913277 bde:AdventureSegmentMember 2021-07-01 2021-09-30 0000913277 bde:PrecisionSportSegmentMember 2021-01-01 2021-09-30 0000913277 bde:OutdoorSegmentMember 2021-01-01 2021-09-30 0000913277 bde:AdventureSegmentMember 2021-01-01 2021-09-30 0000913277 bde:RhinoRackMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000913277 bde:RhinoRackMember bde:ProductTechnologiesMember 2022-01-01 2022-09-30 0000913277 bde:MaxtraxMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000913277 bde:MaxtraxMember bde:ProductTechnologiesMember 2022-01-01 2022-09-30 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2022-09-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-09-30 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2022-06-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-06-30 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-12-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-09-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-06-30 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000913277 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-12-31 0000913277 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000913277 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000913277 2022-11-02 0000913277 us-gaap:RestrictedStockMember bde:TwoThousandFifteenStockIncentivePlanMember 2022-03-04 2022-03-04 0000913277 2022-03-04 0000913277 us-gaap:IndefinitelivedIntangibleAssetsMember bde:AdventureSegmentMember 2022-01-01 2022-09-30 0000913277 bde:AdventureSegmentMember 2022-01-01 2022-09-30 0000913277 bde:RestatedCreditAgreementMember 2022-09-30 0000913277 us-gaap:AustralianTaxationOfficeMember 2022-09-30 0000913277 bde:InlandRevenueDepartmentNewZealandMember 2022-09-30 0000913277 bde:AustrianMinistryOfFinanceMember 2022-09-30 0000913277 bde:RhinoRackMember 2022-01-01 2022-09-30 0000913277 bde:MaxtraxMember 2022-01-01 2022-09-30 0000913277 2018-08-06 2018-08-06 0000913277 us-gaap:FairValueInputsLevel3Member 2022-09-30 0000913277 us-gaap:FairValueInputsLevel1Member 2022-09-30 0000913277 2022-07-01 2022-09-30 0000913277 2022-01-01 2022-09-30 0000913277 2021-07-01 2021-09-30 0000913277 2021-01-01 2021-09-30 0000913277 bde:MaxtraxMember 2021-12-01 0000913277 bde:RhinoRackMember 2021-07-01 0000913277 2022-09-30 0000913277 2021-12-31 bde:segment utr:lb iso4217:EUR iso4217:CAD bde:item iso4217:AUD xbrli:shares xbrli:pure iso4217:USD xbrli:shares iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended: September 30, 2022

or

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _________ to _________

Commission File Number: 001-34767

CLARUS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware | 58-1972600
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)

2084 East 3900 South Salt Lake City, Utah |  | 84124
(Address of principal executive offices) |  | (Zip code)

(801) 278-5552
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $.0001 per share | CLAR | NASDAQ Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ¨ |  | Non-accelerated filer | ¨
Accelerated filer | x |  | Smaller reporting company | ¨
|  |  | Emerging growth company | ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of November 2, 2022, there were 37,036,468 shares of common stock, par value $0.0001, outstanding.

INDEX

CLARUS CORPORATION

PART I | FINANCIAL INFORMATION | Page
Item 1. | Financial Statements (Unaudited) |
| Condensed Consolidated Balance Sheets – September 30, 2022 and December 31, 2021 | 3
| Condensed Consolidated Statements of Comprehensive Loss – Three months ended September 30, 2022 and 2021 | 4
| Condensed Consolidated Statements of Comprehensive (Loss) Income – Nine months ended September 30, 2022 and 2021 | 5
| Condensed Consolidated Statements of Cash Flows – Nine months ended September 30, 2022 and 2021 | 6
| Condensed Consolidated Statements of Stockholders’ Equity – Three and nine months ended September 30, 2022 and 2021 | 7
| Notes to Condensed Consolidated Financial Statements | 9
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 27
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 37
Item 4. | Controls and Procedures | 37
PART II | OTHER INFORMATION |
Item 1. | Legal Proceedings | 39
Item 1A. | Risk Factors | 39
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 40
Item 6. | Exhibits | 41
Signature Page |  | 42

2

PART I. FINANCIAL INFORMATION

I TEM 1. FINANCIAL STATEMENTS

CLARUS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share amounts)
| September 30, 2022 |  | December 31, 2021
Assets |  |  |  |  |
Current assets |  |  |  |  |
Cash | $ | 10,365 |  | $ | 19,465
Accounts receivable, less allowance for |  |  |  |  |
credit losses of $1,200 and $811 |  | 76,468 |  |  | 66,180
Inventories |  | 155,206 |  |  | 129,354
Prepaid and other current assets |  | 14,586 |  |  | 11,831
Income tax receivable |  | 860 |  |  | 116
Total current assets |  | 257,485 |  |  | 226,946
Property and equipment, net |  | 42,140 |  |  | 42,826
Other intangible assets, net |  | 56,789 |  |  | 73,683
Indefinite-lived intangible assets |  | 119,201 |  |  | 128,271
Goodwill |  | 112,247 |  |  | 118,090
Deferred income taxes |  | 22,304 |  |  | 22,433
Other long-term assets |  | 17,775 |  |  | 19,578
Total assets | $ | 627,941 |  | $ | 631,827
Liabilities and Stockholders' Equity |  |  |  |  |
Current liabilities |  |  |  |  |
Accounts payable | $ | 23,640 |  | $ | 31,488
Accrued liabilities |  | 26,271 |  |  | 27,473
Income tax payable |  | 1,109 |  |  | 4,437
Current portion of long-term debt |  | 10,306 |  |  | 9,585
Total current liabilities |  | 61,326 |  |  | 72,983
Long-term debt, net |  | 156,852 |  |  | 131,948
Deferred income taxes |  | 30,704 |  |  | 35,280
Other long-term liabilities |  | 15,970 |  |  | 21,448
Total liabilities |  | 264,852 |  |  | 261,659
Stockholders' Equity |  |  |  |  |
Preferred stock, $0.0001 par value per share; 5,000 |  |  |  |  |
shares authorized; none issued |  | - |  |  | -
Common stock, $0.0001 par value per share; 100,000 shares authorized; |  |  |  |  |
41,625 and 41,105 issued and 37,036 and 37,094 outstanding, respectively |  | 4 |  |  | 4
Additional paid in capital |  | 677,120 |  |  | 662,996
Accumulated deficit |  | (254,313) |  |  | (263,342)
Treasury stock, at cost |  | (32,707) |  |  | (24,440)
Accumulated other comprehensive loss |  | (27,015) |  |  | (5,050)
Total stockholders' equity |  | 363,089 |  |  | 370,168
Total liabilities and stockholders' equity | $ | 627,941 |  | $ | 631,827
See accompanying notes to condensed consolidated financial statements.

‎

3

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
(In thousands, except per share amounts)
| Three Months Ended
| September 30, 2022 |  | September 30, 2021
Sales |  |  |  |  |
Domestic sales | $ | 55,540 |  | $ | 61,259
International sales |  | 60,175 |  |  | 47,712
Total sales |  | 115,715 |  |  | 108,971
Cost of goods sold |  | 76,291 |  |  | 69,792
Gross profit |  | 39,424 |  |  | 39,179
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 32,340 |  |  | 31,314
Transaction costs |  | 858 |  |  | 8,147
Contingent consideration expense |  | 104 |  |  | -
Total operating expenses |  | 33,302 |  |  | 39,461
Operating income (loss) |  | 6,122 |  |  | (282)
Other expense |  |  |  |  |
Interest expense, net |  | (2,216) |  |  | (1,476)
Other, net |  | (1,238) |  |  | 338
Total other expense, net |  | (3,454) |  |  | (1,138)
Income (loss) before income tax |  | 2,668 |  |  | (1,420)
Income tax benefit |  | (83) |  |  | (5,950)
Net income |  | 2,751 |  |  | 4,530
Other comprehensive loss, net of tax: |  |  |  |  |
Foreign currency translation adjustment |  | (11,386) |  |  | (8,933)
Unrealized gain on hedging activities |  | 268 |  |  | 268
Other comprehensive loss |  | (11,118) |  |  | (8,665)
Comprehensive loss | $ | (8,367) |  | $ | (4,135)
Net income per share: |  |  |  |  |
Basic | $ | 0.07 |  | $ | 0.13
Diluted |  | 0.07 |  |  | 0.13
Weighted average shares outstanding: |  |  |  |  |
Basic |  | 37,369 |  |  | 33,800
Diluted |  | 39,580 |  |  | 36,164
See accompanying notes to condensed consolidated financial statements. |  |  |  |  |

‎

4

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(Unaudited)
(In thousands, except per share amounts)
| Nine Months Ended
| September 30, 2022 |  | September 30, 2021
Sales |  |  |  |  |
Domestic sales | $ | 181,920 |  | $ | 160,708
International sales |  | 162,004 |  |  | 96,903
Total sales |  | 343,924 |  |  | 257,611
Cost of goods sold |  | 216,566 |  |  | 163,361
Gross profit |  | 127,358 |  |  | 94,250
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 101,959 |  |  | 72,903
Transaction costs |  | 2,880 |  |  | 9,272
Contingent consideration expense |  | 493 |  |  | -
Total operating expenses |  | 105,332 |  |  | 82,175
Operating income |  | 22,026 |  |  | 12,075
Other expense |  |  |  |  |
Interest expense, net |  | (5,060) |  |  | (1,926)
Other, net |  | (2,648) |  |  | (4,263)
Total other expense, net |  | (7,708) |  |  | (6,189)
Income before income tax |  | 14,318 |  |  | 5,886
Income tax expense (benefit) |  | 2,494 |  |  | (6,161)
Net income |  | 11,824 |  |  | 12,047
Other comprehensive (loss) income, net of tax: |  |  |  |  |
Foreign currency translation adjustment |  | (22,941) |  |  | (9,654)
Unrealized gain on hedging activities |  | 976 |  |  | 1,272
Other comprehensive loss |  | (21,965) |  |  | (8,382)
Comprehensive (loss) income | $ | (10,141) |  | $ | 3,665
Net income per share: |  |  |  |  |
Basic | $ | 0.32 |  | $ | 0.37
Diluted |  | 0.30 |  |  | 0.35
Weighted average shares outstanding: |  |  |  |  |
Basic |  | 37,256 |  |  | 32,159
Diluted |  | 39,694 |  |  | 34,044
See accompanying notes to condensed consolidated financial statements.

‎

5

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|  | Nine Months Ended
|  | September 30, 2022 |  | September 30, 2021
| Cash Flows From Operating Activities: |  |  |  |  |
| Net income | $ | 11,824 |  | $ | 12,047
| Adjustments to reconcile net income to net cash used in operating activities: |  |  |  |  |
| Depreciation of property and equipment |  | 5,800 |  |  | 4,336
| Amortization of other intangible assets |  | 11,740 |  |  | 5,971
| Amortization of debt issuance costs |  | 593 |  |  | 335
| Gain on disposition of property and equipment |  | (41) |  |  | (2)
| Noncash lease expense |  | 2,412 |  |  | 1,507
| Contingent consideration expense |  | 468 |  |  | -
| Stock-based compensation |  | 9,142 |  |  | 6,414
| Deferred income taxes |  | (410) |  |  | (7,006)
| Changes in operating assets and liabilities, net of acquisitions: |  |  |  |  |
| Accounts receivable |  | (24,941) |  |  | (13,079)
| Inventories |  | (30,243) |  |  | (25,181)
| Prepaid and other assets |  | (2,126) |  |  | (5,912)
| Accounts payable |  | 4,662 |  |  | 1,358
| Accrued liabilities |  | (2,756) |  |  | 2,200
| Income taxes |  | (3,870) |  |  | (89)
| Net cash used in operating activities |  | (17,746) |  |  | (17,101)
| Cash Flows From Investing Activities: |  |  |  |  |
| Purchase of businesses, net of cash received |  | - |  |  | (135,627)
| Proceeds from disposition of property and equipment |  | 438 |  |  | 25
| Purchases of property and equipment |  | (6,216) |  |  | (5,579)
| Net cash used in investing activities |  | (5,778) |  |  | (141,181)
| Cash Flows From Financing Activities: |  |  |  |  |
| Proceeds from revolving credit facilities |  | 98,991 |  |  | 87,703
| Repayments on revolving credit facilities |  | (72,804) |  |  | (37,871)
| Repayments on term loans |  | (125,191) |  |  | (5,814)
| Proceeds from issuance of term loans |  | 125,000 |  |  | 109,154
| Payment of debt issuance costs |  | (1,385) |  |  | (722)
| Purchase of treasury stock |  | (8,267) |  |  | (651)
| Proceeds from exercise of stock options |  | 2,721 |  |  | 1,652
| Cash dividends paid |  | (2,795) |  |  | (2,410)
| Payment of contingent consideration |  | (943) |  |  | -
| Net cash provided by financing activities |  | 15,327 |  |  | 151,041
| Effect of foreign exchange rates on cash |  | (903) |  |  | (378)
| Change in cash |  | (9,100) |  |  | (7,619)
| Cash, beginning of year |  | 19,465 |  |  | 17,789
| Cash, end of period | $ | 10,365 |  | $ | 10,170
| Supplemental Disclosure of Cash Flow Information: |  |  |  |  |
| Cash paid for income taxes | $ | 7,155 |  | $ | 353
| Cash paid for interest | $ | 4,107 |  | $ | 1,389
| Supplemental Disclosures of Non-Cash Investing and Financing Activities: |  |  |  |  |
| Stock issued for business acquisitions | $ | 2,261 |  | $ | 55,333
| Contingent consideration for business acquisitions | $ | - |  | $ | 3,564
| Property and equipment purchased with accounts payable | $ | 127 |  | $ | 57
| Lease liabilities arising from obtaining right of use assets | $ | 1,324 |  | $ | 6,421
| Unpaid debt issuance costs | $ | - |  | $ | 270
See accompanying notes to condensed consolidated financial statements.

‎

6

CLARUS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
(In thousands, except per share amounts)
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |
|  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  | Total
| Common Stock |  | Paid-In |  | Accumulated |  | Treasury Stock |  | Comprehensive |  | Stockholders'
| Shares |  | Amount |  | Capital |  | Deficit |  | Shares |  | Amount |  | Income (Loss) |  | Equity
Balance, December 31, 2020 |  | 35,198 |  | $ | 4 |  | $ | 513,979 |  | $ | (286,100) |  |  | (3,970) |  | $ | (23,789) |  | $ | 500 |  | $ | 204,594
Net income |  | - |  |  | - |  |  | - |  |  | 5,677 |  |  | - |  |  | - |  |  | - |  |  | 5,677
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (120) |  |  | (120)
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (783) |  |  | - |  |  | - |  |  | - |  |  | (783)
Purchase of treasury stock |  | - |  |  | - |  |  | - |  |  | - |  |  | (41) |  |  | (651) |  |  | - |  |  | (651)
Stock-based compensation expense |  | - |  |  | - |  |  | 1,524 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 1,524
Proceeds from exercise of options |  | 127 |  |  | - |  |  | 246 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 246
Balance, March 31, 2021 |  | 35,325 |  | $ | 4 |  | $ | 515,749 |  | $ | (281,206) |  |  | (4,011) |  | $ | (24,440) |  | $ | 380 |  | $ | 210,487
Net income |  | - |  |  | - |  |  | - |  |  | 1,840 |  |  | - |  |  | - |  |  | - |  |  | 1,840
Other comprehensive income |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 403 |  |  | 403
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (782) |  |  | - |  |  | - |  |  | - |  |  | (782)
Stock-based compensation expense |  | - |  |  | - |  |  | 1,826 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 1,826
Proceeds from exercise of options |  | 171 |  |  | - |  |  | 1,406 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 1,406
Balance, June 30, 2021 |  | 35,496 |  | $ | 4 |  | $ | 518,981 |  | $ | (280,148) |  |  | (4,011) |  | $ | (24,440) |  | $ | 783 |  | $ | 215,180
Net income |  | - |  |  | - |  |  | - |  |  | 4,530 |  |  | - |  |  | - |  |  | - |  |  | 4,530
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (8,665) |  |  | (8,665)
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (845) |  |  | - |  |  | - |  |  | - |  |  | (845)
Stock-based compensation expense |  | - |  |  | - |  |  | 3,064 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3,064
Shares issued in business acquisition |  | 2,315 |  |  | - |  |  | 55,333 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 55,333
Balance, September 30, 2021 |  | 37,811 |  | $ | 4 |  | $ | 577,378 |  | $ | (276,463) |  |  | (4,011) |  | $ | (24,440) |  | $ | (7,882) |  | $ | 268,597

7

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated |  |  |
|  |  |  |  |  |  | Additional |  |  |  |  |  |  |  |  |  |  | Other |  | Total
| Common Stock |  | Paid-In |  | Accumulated |  | Treasury Stock |  | Comprehensive |  | Stockholders'
| Shares |  | Amount |  | Capital |  | Deficit |  | Shares |  | Amount |  | Income (Loss) |  | Equity
Balance, December 31, 2021 |  | 41,105 |  | $ | 4 |  | $ | 662,996 |  | $ | (263,342) |  |  | (4,011) |  | $ | (24,440) |  | $ | (5,050) |  | $ | 370,168
Net income |  | - |  |  | - |  |  | - |  |  | 5,309 |  |  | - |  |  | - |  |  | - |  |  | 5,309
Other comprehensive income |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 6,163 |  |  | 6,163
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (930) |  |  | - |  |  | - |  |  | - |  |  | (930)
Purchase of treasury stock |  | - |  |  | - |  |  | - |  |  | - |  |  | (51) |  |  | (1,097) |  |  | - |  |  | (1,097)
Stock-based compensation expense |  | - |  |  | - |  |  | 3,367 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3,367
Proceeds from exercise of options |  | 167 |  |  | - |  |  | 126 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 126
Balance, March 31, 2022 |  | 41,272 |  | $ | 4 |  | $ | 666,489 |  | $ | (258,963) |  |  | (4,062) |  | $ | (25,537) |  | $ | 1,113 |  | $ | 383,106
Net income |  | - |  |  | - |  |  | - |  |  | 3,764 |  |  | - |  |  | - |  |  | - |  |  | 3,764
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (17,010) |  |  | (17,010)
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (931) |  |  | - |  |  | - |  |  | - |  |  | (931)
Stock-based compensation expense |  | - |  |  | - |  |  | 3,555 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3,555
Proceeds from exercise of options |  | 56 |  |  | - |  |  | 542 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 542
Balance, June 30, 2022 |  | 41,328 |  | $ | 4 |  | $ | 670,586 |  | $ | (256,130) |  |  | (4,062) |  | $ | (25,537) |  | $ | (15,897) |  | $ | 373,026
Net income |  | - |  |  | - |  |  | - |  |  | 2,751 |  |  | - |  |  | - |  |  | - |  |  | 2,751
Other comprehensive loss |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | (11,118) |  |  | (11,118)
Cash dividends ($0.025 per share) |  | - |  |  | - |  |  | - |  |  | (934) |  |  | - |  |  | - |  |  | - |  |  | (934)
Purchase of treasury stock |  | - |  |  | - |  |  |  |  |  |  |  |  | (527) |  |  | (7,170) |  |  | - |  |  | (7,170)
Stock-based compensation expense |  | - |  |  | - |  |  | 2,220 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 2,220
Proceeds from exercise of options |  | 189 |  |  | - |  |  | 2,053 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 2,053
Shares issued in business acquisition |  | 108 |  |  | - |  |  | 2,261 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 2,261
Balance, September 30, 2022 |  | 41,625 |  | $ | 4 |  | $ | 677,120 |  | $ | (254,313) |  |  | (4,589) |  | $ | (32,707) |  | $ | (27,015) |  | $ | 363,089
See accompanying notes to condensed consolidated financial statements.

8

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(in thousands, except per share amounts)

NOT E 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed consolidated financial statements of Clarus Corporation and subsidiaries (which may be referred to as the “Company,” “Clarus,” “we,” “us” or “our”) as of September 30, 2022 and December 31, 2021 and for the three and nine months ended September 30, 2022 and 2021, have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), instructions to the Quarterly Report on Form 10-Q, and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments, except otherwise disclosed) necessary for a fair presentation of the unaudited condensed consolidated financial statements have been included. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be obtained for the year ending December 31, 2022. These interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 7, 2022.

Nature of Business

Headquartered in Salt Lake City, Utah, we are a global leading designer, developer, manufacturer and distributor of best-in-class outdoor equipment and lifestyle products focused on the outdoor and consumer enthusiast markets. Our mission is to identify, acquire and grow outdoor “super fan” brands through our unique “innovate and accelerate” strategy. We define a “super fan” brand as a brand that creates the world’s pre-eminent, performance-defining product that the best-in-class user cannot live without. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond®, Sierra®, Barnes®, Rhino-Rack® and MAXTRAX® brand names through outdoor specialty and online retailers, our own websites, distributors and original equipment manufacturers.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The more significant estimates relate to the fair value of net assets acquired in business combinations, excess or obsolete inventory, allowance for credit losses, contingent consideration liabilities, and valuation of deferred tax assets, long-lived assets, goodwill and other intangible assets. We base our estimates on historical experience, projected future cash flows, and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.

Significant Accounting Policies

Accounting Pronouncements adopted during 2022

During the nine months ended September 30, 2022, the Company adopted Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The ASU was adopted on a prospective basis. This ASU provides temporary optional expedients and exceptions to existing guidance on contract modifications and hedge accounting to facilitate the market transition from existing reference rates, such as the London Inter-Bank Offered Rate (“LIBOR”) which was phased out in 2021, to alternate reference rates, such as the Secured Overnight Financing Rate (“SOFR”). The adoption of this standard did not have a material effect on the Company’s consolidated financial statements and related disclosures.

NOTE 2. ACQUISITIONS

MAXTRAX

On November 26, 2021, Clarus entered into a Share and Unit Purchase Agreement (the “MAXTRAX Purchase Agreement”) to acquire MaxTrax Australia Pty Ltd (“MAXTRAX”), which subsequently closed on December 1, 2021. All United States dollar amounts contained herein are based on the exchange rates in effect for Australian dollars ($AUD) and the market value of the Company’s common stock at the time of closing of the acquisition of MAXTRAX (the “MAXTRAX Acquisition”).

The Company acquired MAXTRAX for an aggregate purchase price of $AUD 49,744 (approximately $35,475), subject to a post-closing adjustment, comprised of $AUD 37,551 (approximately $26,780) cash, 107 shares of the Company’s common stock valued at $2,594, and additional consideration described below. The MAXTRAX Purchase Agreement also provides for the payment of additional consideration in the form of shares of the Company’s common stock valued at $AUD 6,250 (approximately $4,457) split equally on

9

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

June 30, 2022 and 2023. During the three months ended September 30, 2022, approximately 108 shares of the Company’s common stock were issued in accordance with the MAXTRAX Purchase Agreement as additional consideration. The MAXTRAX Purchase Agreement provides for the payment of additional contingent consideration up to $AUD 6,250 (approximately $4,457) in cash if certain future net sales thresholds are met during 2022 and 2023 (the “MAXTRAX Contingent Consideration”). The Company estimated the initial fair value of the MAXTRAX Contingent Consideration to be $AUD 2,307 (approximately $1,644) and has recorded this liability within accrued liabilities and other long-term liabilities. The net sales threshold required for the payment of the 2022 portion of the MAXTRAX Contingent Consideration was met during the 2022 measurement period ended June 30, 2022. See Note 10 for discussion regarding the valuation of the MAXTRAX Contingent Consideration as of September 30, 2022. The acquisition was accounted for as a business combination.

Rhino-Rack

On May 30, 2021, Clarus entered into a Share Sale and Purchase Agreement (the “Purchase Agreement”) to acquire Rhino-Rack Holdings Pty Ltd (“Rhino-Rack”), which subsequently closed on July 1, 2021. All United States dollar amounts contained herein are based on the exchange rates in effect for Australian dollars ($AUD) and the market value of the Company’s common stock at the time of closing of the acquisition of Rhino-Rack (the “Rhino-Rack Acquisition”).

The Company acquired Rhino-Rack for an aggregate purchase price of approximately $AUD 269,696 (approximately $202,488), subject to a post-closing adjustment, comprised of approximately $AUD 191,249 (approximately $143,590) cash, 2,315 shares of the Company’s common stock valued at $55,333, and additional contingent consideration described below. The Purchase Agreement also provides for the payment of additional contingent consideration up to approximately $AUD 10,000 (approximately $7,508) if certain future net sales thresholds are met (the “Rhino-Rack Contingent Consideration”). The Company estimated the initial fair value of the Rhino-Rack Contingent Consideration to be approximately $AUD 4,747 (approximately $3,565) and has recorded this liability within accrued liabilities. The net sales threshold required for the payment of the Rhino-Rack Contingent Consideration was not met during the measurement period ended June 30, 2022. See Note 10 for discussion regarding the valuation of the Rhino-Rack Contingent Consideration as of September 30, 2022. The acquisition was accounted for as a business combination.

The Company believes the acquisitions of MAXTRAX and Rhino-Rack are expected to provide the Company with a greater combined global revenue base, increased gross margins, profitability and free cash flows, and access to increased liquidity to further seek to acquire and grow businesses.

The following table is a reconciliation to the fair value of the purchase consideration and how the purchase consideration is allocated to assets acquired and liabilities assumed which have been estimated at their fair values. The fair value estimates for the purchase price allocation for MAXTRAX and Rhino-Rack are based on the Company’s best estimates and assumptions as of the reporting date and are considered preliminary. Since our initial purchase price allocation for the MAXTRAX acquisition, we have increased the fair value of accrued liabilities assumed and goodwill by $741. These adjustments were made after receiving certain information, which existed as of the date of acquisition, related to the fair value of assumed liabilities and such amounts were recorded during the first quarter of 2022. The fair value measurements of identifiable assets and liabilities, and the resulting goodwill related to the MAXTRAX Acquisition are subject to change and the final purchase price allocations could be different from the amounts presented below. We expect to finalize the valuation of MAXTRAX as soon as practicable, but not later than one year from the date of the acquisition. The fair value measurements for the acquisition of Rhino-Rack have been completed. The excess of purchase consideration over the assets acquired and liabilities assumed is recorded as goodwill. Goodwill for MAXTRAX and Rhino-Rack is included in the Adventure segment. The goodwill consists largely of the growth and profitability expected from these acquisitions.

10

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

|  | MAXTRAX |  | Rhino-Rack
|  | December 1, 2021 |  | July 1, 2021
|  | Number of Shares |  | Estimated Fair Value |  | Number of Shares |  | Estimated Fair Value
Cash paid |  | - |  | $ | 26,780 |  | - |  | $ | 143,590
Issuance of shares of Clarus Corporation |  | 107 |  |  | 2,594 |  | 2,315 |  |  | 55,333
Future issuance of shares of Clarus Corporation |  | - |  |  | 4,457 |  | - |  |  | -
Contingent consideration |  | - |  |  | 1,644 |  | - |  |  | 3,565
Total purchase consideration |  | 107 |  | $ | 35,475 |  | 2,315 |  | $ | 202,488
Assets acquired and liabilities assumed |  |  |  |  |  |  |  |  |  |
Assets |  |  |  |  |  |  |  |  |  |
Cash |  |  |  | $ | 1,869 |  |  |  | $ | 7,513
Accounts receivable |  |  |  |  | 2,791 |  |  |  |  | 10,769
Inventories |  |  |  |  | 1,819 |  |  |  |  | 27,046
Prepaid and other current assets |  |  |  |  | 883 |  |  |  |  | 644
Property and equipment |  |  |  |  | 139 |  |  |  |  | 4,619
Other intangible assets |  |  |  |  | 10,341 |  |  |  |  | 55,400
Indefinite-lived intangible assets |  |  |  |  | 10,555 |  |  |  |  | 72,800
Goodwill |  |  |  |  | 15,199 |  |  |  |  | 78,347
Other long-term assets |  |  |  |  | 979 |  |  |  |  | 11,468
Total assets |  |  |  |  | 44,575 |  |  |  |  | 268,606
Liabilities |  |  |  |  |  |  |  |  |  |
Accounts payable and accrued liabilities |  |  |  |  | 2,176 |  |  |  |  | 16,511
Income tax payable |  |  |  |  | 251 |  |  |  |  | 3,413
Current portion of long-term debt |  |  |  |  | - |  |  |  |  | 607
Long-term debt |  |  |  |  | - |  |  |  |  | 2,107
Deferred income taxes |  |  |  |  | 5,863 |  |  |  |  | 32,451
Other long-term liabilities |  |  |  |  | 810 |  |  |  |  | 11,029
Total liabilities |  |  |  |  | 9,100 |  |  |  |  | 66,118
Net Book Value Acquired |  |  |  | $ | 35,475 |  |  |  | $ | 202,488

The estimated fair value of inventory was recorded at expected sales price less cost to sell plus a reasonable profit margin for selling efforts.

11

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

In connection with the acquisitions, the Company acquired exclusive rights to MAXTRAX’s and Rhino-Rack’s trademarks, customer relationships, and product technologies. The amounts assigned to each class of intangible asset, other than goodwill acquired, and the related average useful lives as of the acquisition dates, are as follows:

| MAXTRAX |  | Rhino-Rack
|  |  | Average |  |  |  | Average
| Gross | Useful Life |  | Gross | Useful Life
Intangibles subject to amortization |  |  |  |  |  |  |  |  |
Customer relationships | $ | 8,986 |  | 13.5 years |  | $ | 40,400 |  | 13.5 years
Product technologies |  | 1,355 |  | 7.0 years |  |  | 15,000 |  | 10.0 years
Intangibles not subject to amortization |  |  |  |  |  |  |  |  |
Trademarks |  | 10,555 |  | N/A |  |  | 72,800 |  | N/A
| $ | 20,896 |  | 12.6 years |  | $ | 128,200 |  | 12.6 years

The full amount of goodwill of $15,199 for MAXTRAX and $78,347 for Rhino-Rack is expected to be non-deductible for tax purposes. No pre-existing relationships existed between the Company and MAXTRAX and Rhino-Rack or their sellers prior to the acquisition. MAXTRAX and Rhino-Rack revenue and operating income are included in the Adventure segment.

The following unaudited pro forma results are based on the individual historical results of the Company, MAXTRAX and Rhino-Rack, with adjustments to give effect as if the acquisitions and borrowings used to finance the acquisitions had occurred on January 1, 2020, after giving effect to certain adjustments, including the amortization of intangible assets, depreciation of fixed assets, interest expense and taxes and assumes the purchase price was allocated to the assets purchased and liabilities assumed based on their fair market values at the date of purchase.

| Three Months Ended |  | Nine Months Ended
| September 30, 2021 |  | September 30, 2021
Sales | $ | 113,467 |  | $ | 319,559
Net income | $ | 17,144 |  | $ | 28,175
Net income per share - basic | $ | 0.51 |  | $ | 0.88
Net income per share - diluted | $ | 0.47 |  | $ | 0.83

The unaudited pro forma information is presented for illustrative purposes only and is not necessarily indicative of the operating results that would have occurred had the transactions been consummated as of January 1, 2020. Furthermore, such pro forma information is not necessarily indicative of future operating results of the combined companies and should not be construed as representative of the operating results of the combined companies for any future dates or periods.

NOTE 3. INVENTORIES

Inventories, as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022 |  | December 31, 2021
Finished goods | $ | 110,916 |  | $ | 86,647
Work-in-process |  | 8,829 |  |  | 10,336
Raw materials and supplies |  | 35,461 |  |  | 32,371
| $ | 155,206 |  | $ | 129,354

12

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 4. PROPERTY AND EQUIPMENT

Property and equipment, net, as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022 |  | December 31, 2021
Land | $ | 4,160 |  | $ | 4,160
Building and improvements |  | 17,237 |  |  | 16,403
Furniture and fixtures |  | 7,316 |  |  | 6,677
Computer hardware and software |  | 8,482 |  |  | 7,512
Machinery and equipment |  | 35,313 |  |  | 33,581
Construction in progress |  | 4,198 |  |  | 4,312
|  | 76,706 |  |  | 72,645
Less accumulated depreciation |  | (34,566) |  |  | (29,819)
| $ | 42,140 |  | $ | 42,826

Depreciation expense for the three months ended September 30, 2022 and 2021 was $2,091 and $1,631, respectively, and for the nine months ended September 30, 2022 and 2021 was $5,800 and $4,336, respectively.

NOTE 5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

The following table summarizes the balances in goodwill by segment:

| Outdoor |  | Precision Sport |  | Adventure |  | Total
Balance at December 31, 2021 | $ | - |  | $ | 26,715 |  | $ | 91,375 |  | $ | 118,090
Acquisition adjustment |  | - |  |  | - |  |  | 741 |  |  | 741
Impact of foreign currency exchange rates |  | - |  |  | - |  |  | (6,584) |  |  | (6,584)
Balance at September 30, 2022 | $ | - |  | $ | 26,715 |  | $ | 85,532 |  | $ | 112,247

We assess the recoverability of our reporting unit’s carrying value of goodwill annually or more often if events or circumstances make it more likely than not that the fair value of the reporting unit is less than its carrying value, such as a significant adverse change in the business climate. If the fair value of the reporting unit is less than its carrying amount, an impairment loss is recognized for the excess carrying amount over the fair value computation. We estimate the reporting unit’s fair value using a combination of the income approach based upon projected discounted cash flows of the reporting unit and the market approach based upon the market multiple of comparable publicly traded companies.

Under the income approach, the estimated discounted cash flows are based on the best information available to us at the time, including supportable assumptions and projections we believe are reasonable. Our discounted cash flow estimates use discount rates that correspond to a weighted-average cost of capital consistent with a market-participant view. The discount rates are consistent with those used for investment decisions and take into account our future operating plans and strategies. Certain other key assumptions utilized, including revenue projections, costs of goods sold, operating expenses and effective tax rates, are based on estimates consistent with those utilized in our annual budgeting and planning process that we believe are reasonable.

The market approach identifies the EBITDA multiples of comparable publicly traded companies. The reporting unit’s EBITDA is multiplied by the market multiple to estimate its current estimated fair value.

Due to a weakening global economy, driven by higher inflation and interest rates, and other factors affecting the market for our Adventure reporting unit products, we reduced our sales projections for the remainder of 2022, and our forecasts for 2023 and beyond in our Adventure reporting unit. As a result, we determined that a triggering event had occurred during the quarter ended September 30, 2022, with respect to our Adventure reporting unit, which required that we perform a quantitative assessment. We assessed the fair value

13

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

of this reporting unit using the income-based and market-based approaches described above. As a result of this assessment, the fair value of our Adventure reporting unit exceeded the related carrying value by approximately 11%, thus no impairment of goodwill was recorded.

Indefinite-Lived Intangible Assets

The following table summarizes the changes in indefinite-lived intangible assets:

Balance at December 31, 2021 | $ | 128,271
Impact of foreign currency exchange rates |  | (9,070)
Balance at September 30, 2022 | $ | 119,201

Similar to the goodwill impairment assessment, Management performs an interim indefinite-lived intangible asset impairment assessment whenever events or circumstances make it more likely than not that an impairment may have occurred, such as a significant adverse change in the business climate. If the carrying value of the indefinite-lived asset is higher than its fair value, the asset is deemed to be impaired and the impairment charge is estimated as the difference.

The Company calculates the fair value of its indefinite-lived intangible assets using the income approach, specifically the relief-from-royalty method. The relief-from-royalty method is used to estimate the cost savings that accrue to the owner of an intangible asset who would otherwise have to pay royalties or license fees on revenues earned through the use of the asset. Internally forecasted revenues, which the Company believes reasonably approximate market participant assumptions, are multiplied by a royalty rate to arrive at the estimated net after tax cost savings. The royalty rate used in the analysis is based on an analysis of empirical, market-derived royalty rates for comparable intangible assets. The net after tax cost savings are discounted using the same weighted-average cost of capital discount rate developed for purposes of the Company's quantitative goodwill impairment test.

As described above, we determined that a triggering event had occurred during the quarter ended September 30, 2022, with respect to certain indefinite-lived intangible assets within our Adventure reporting unit, which required that we perform a quantitative assessment. We assessed the fair value of the Adventure reporting unit indefinite-lived intangible assets using the relief-from-royalty method described above. As a result of this assessment, the fair value of our Adventure reporting unit indefinite-lived intangible assets exceeded the related carrying value by approximately 14%, thus no impairment was recorded.

If we do not achieve the results reflected in the forecasted estimates utilized in our impairment assessments, or if there are changes to market assumptions, our valuation of the reporting unit, including related indefinite-lived intangible assets, could be adversely affected, and we may be required to impair a portion or all of the related goodwill, indefinite-lived intangibles, and other long-lived assets which would adversely affect our operating results in the period of impairment.

Trademarks classified as indefinite-lived intangible assets by brand as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022 |  | December 31, 2021
Black Diamond | $ | 19,600 |  | $ | 19,600
PIEPS |  | 2,734 |  |  | 3,166
Sierra |  | 18,900 |  |  | 18,900
Barnes |  | 5,600 |  |  | 5,600
Rhino-Rack |  | 62,784 |  |  | 70,278
MAXTRAX |  | 9,583 |  |  | 10,727
| $ | 119,201 |  | $ | 128,271

‎

14

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Other Intangible Assets, net

The following table summarizes the changes in gross other intangible assets:

Gross balance at December 31, 2021 | $ | 104,681
Impact of foreign currency exchange rates |  | (6,788)
Gross balance at September 30, 2022 | $ | 97,893

Other intangible assets, net of amortization as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022
| Gross |  | Accumulated Amortization |  | Net |  | Weighted Average Useful Life
Intangibles subject to amortization |  |  |  |  |  |  |  |  |  |  |
Customer relationships | $ | 75,257 |  | $ | (31,393) |  | $ | 43,864 |  |  | 13.8 years
Product technologies |  | 20,426 |  |  | (7,971) |  |  | 12,455 |  |  | 10.2 years
Tradename / trademark |  | 1,263 |  |  | (793) |  |  | 470 |  |  | 9.4 years
Core technologies |  | 947 |  |  | (947) |  |  | - |  |  | 10.0 years
| $ | 97,893 |  | $ | (41,104) |  | $ | 56,789 |  |  | 13.0 years
| December 31, 2021
| Gross |  | Accumulated Amortization |  | Net |  | Weighted Average Useful Life
Customer relationships | $ | 80,078 |  | $ | (23,804) |  | $ | 56,274 |  |  | 13.8 years
Product technologies |  | 22,393 |  |  | (5,557) |  |  | 16,836 |  |  | 10.2 years
Tradename / trademark |  | 1,263 |  |  | (690) |  |  | 573 |  |  | 9.4 years
Core technologies |  | 947 |  |  | (947) |  |  | - |  |  | 10.0 years
| $ | 104,681 |  | $ | (30,998) |  | $ | 73,683 |  |  | 12.9 years

Amortization expense for the three months ended September 30, 2022 and 2021, was $3,683 and $3,577, respectively, and for the nine months ended September 30, 2022 and 2021 was $11,740 and $5,971, respectively. Future amortization expense for other intangible assets as of September 30, 2022 is as follows:

Years Ending December 31, | Amortization Expense
2022 (excluding the nine months ended September 30, 2022) | $ | 3,549
2023 |  | 12,351
2024 |  | 10,390
2025 |  | 8,408
2026 |  | 6,439
2027 |  | 4,692
Thereafter |  | 10,960
| $ | 56,789

15

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 6. ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES

Accrued liabilities as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022 |  | December 31, 2021
Accrued payroll and related items | $ | 4,834 |  | $ | 5,029
Accrued bonus |  | 2,151 |  |  | 3,615
Accrued warranty |  | 1,515 |  |  | 1,529
Current lease liabilities |  | 2,713 |  |  | 2,824
Accrued commissions |  | 823 |  |  | 811
Contingent consideration liabilities |  | 1,518 |  |  | 2,791
Accrued excise tax |  | 1,105 |  |  | 724
Other |  | 11,612 |  |  | 10,150
| $ | 26,271 |  | $ | 27,473

Other long-term liabilities as of September 30, 2022 and December 31, 2021, were as follows:

| September 30, 2022 |  | December 31, 2021
Long-term lease liability | $ | 13,052 |  | $ | 15,111
Deferred stock consideration for business acquisition |  | 2,023 |  |  | 4,530
Contingent consideration liability |  | - |  |  | 694
Other |  | 895 |  |  | 1,113
| $ | 15,970 |  | $ | 21,448

NOTE 7. LONG-TERM DEBT

Long-term debt as of September 30, 2022 and December 31, 2021, was as follows:

| September 30, 2022 |  | December 31, 2021
Revolving credit facility (a) | $ | 44,688 |  | $ | 18,501
Other debt (b) |  | 1,108 |  |  | 1,467
Term loan (c) |  | 121,875 |  |  | 121,874
Debt issuance costs |  | (513) |  |  | (309)
|  | 167,158 |  |  | 141,533
Less current portion |  | (10,306) |  |  | (9,585)
| $ | 156,852 |  | $ | 131,948

On January 3, 2022, the Company and certain of its direct and indirect subsidiaries entered into Amendment No. 4 (“Amendment No. 4”) to the existing credit agreement, dated as of May 3, 2019 (the “Existing Credit Agreement”) by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto. Amendment No. 4, among other things, permits (i) the Company to borrow in Australian Dollars and New Zealand Dollars in order to support the operations of the Company in Australia and New Zealand and (ii) provides for addbacks to EBITDA, for debt covenant purposes, (as defined in the Existing Credit Agreement) under the Existing Credit Agreement for expenses relating to activities in respect of acquisitions, dispositions, investments and financings (whether or not these transactions are actually consummated).

On April 18, 2022 (the “Effective Date”), the Company and certain of its direct and indirect subsidiaries entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto (the “Restated Credit Agreement”) pursuant to which the Existing Credit Agreement was amended and restated in its entirety.

16

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The Restated Credit Agreement provides for borrowings of up to $300,000 under a secured revolving credit facility (the “Revolving Loans”) (including up to $5,000 for letters of credit), and borrowings of up to $125,000 under a secured term loan facility (the “Term Loans”). The Restated Credit Agreement also permits the Company, subject to certain requirements, to arrange with lenders for an aggregate of up to $175,000 of additional revolving and/or term loan commitments (both of which are currently uncommitted), for potential aggregate revolving and term loan commitments under the Restated Credit Agreement of up to $600,000. The Restated Credit Agreement matures on April 18, 2027 (the “Maturity Date”), at which time the revolving commitments thereunder will terminate and all outstanding Revolving Loans and Term Loans, together with all accrued and unpaid interest thereon, must be repaid.

All obligations under the Restated Credit Agreement are secured by our subsidiary equity interests, as well as accounts receivable, inventory, intellectual property and certain other assets owned by the Company. The Restated Credit Agreement contains restrictions on the Company’s ability to pay dividends or make distributions or other restricted payments if certain conditions in the Restated Credit Agreement are not fulfilled. The Restated Credit Agreement also includes other customary affirmative and negative covenants, including financial covenants relating to the Company’s consolidated total leverage ratio and fixed charge coverage ratio. The Company was in compliance with the debt covenants set forth in the Credit Agreement as of September 30, 2022.

(a)As of September 30, 2022, the Company had drawn $44,688 on the $300,000 revolving commitment that was available under the Restated Credit Agreement, with a maturity date of April 18, 2027. The Company pays interest monthly on any borrowings on the Restated Credit Agreement. As of September 30, 2022 and December 31, 2021, the rates were approximately 5.0% and 2.4%, respectively.

(b)Foreign subsidiaries of the Company have a revolving credit facility and term debt with financial institutions which mature between August 22, 2022 and August 8, 2024. The foreign subsidiaries pay interest monthly on any borrowings on the credit facilities as well as monthly payments on the term debt. As of September 30, 2022, the interest rates ranged between approximately 1.3% and 4.5% and as of December 31, 2021, the interest rates ranged between approximately 1.3% and 5.2%. The credit facilities are secured by certain assets of the foreign subsidiaries.

(c)The Company is required to repay the term loan through quarterly payments of $1,563 each beginning with June 30, 2022, increasing to $3,125 each beginning with June 30, 2023, and any remaining obligations will be repaid in full on the maturity date of the Restated Credit Agreement of April 18, 2027. The Company pays interest monthly on any borrowings on the Restated Credit Agreement. As of September 30, 2022 and December 31, 2021, the rates were approximately 5.0% and 2.4%, respectively.

NOTE 8. DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s primary exchange rate risk management objective is to mitigate the uncertainty of anticipated cash flows attributable to changes in foreign currency exchange rates. The Company primarily focuses on mitigating changes in cash flows resulting from sales denominated in currencies other than the U.S. dollar. The Company manages this risk primarily by using currency forward and option contracts. If the anticipated transactions are deemed probable, the resulting relationships are formally designated as cash flow hedges. The Company accounts for these contracts as cash flow hedges and tests effectiveness by determining whether changes in the expected cash flow of the derivative offset, within a range, changes in the expected cash flow of the hedged item.

As of September 30, 2022, the Company held commodity derivative contracts, with remaining maturities of less than one year, to mitigate the risk of commodity price fluctuations associated with raw material costs. The notional amount of the commodity derivative contracts as of September 30, 2022 was 771 pounds. These contracts are not designated as accounting hedges and the changes in fair value of the instruments are recognized in earnings. During the three and nine months ended September 30, 2022, losses of $(322) and $(875), respectively, were recorded in other, net expense.

During the nine months ending September 30, 2021, the Company held currency forward contracts to mitigate currency fluctuations related to the cash purchase price of Rhino-Rack totaling $AUD 193,650 with a maturity date of July 1, 2021. These contracts were not designated as accounting hedges and the changes in fair value of the instruments were recognized in earnings. During the three and nine months ended September 30, 2021, gains (losses) of $232 and $(4,281) were recorded in other, net expense, respectively.

At September 30, 2022, the Company’s derivative contracts had remaining maturities of less than one year. The counterparties to these transactions had both long-term and short-term investment grade credit ratings. The maximum net exposure of the Company’s credit risk to the counterparties is generally limited to the aggregate unrealized loss of all contracts with that counterparty. At September 30, 2022, there was no such exposure to the counterparties. The Company’s exposure of counterparty credit risk is limited to the aggregate unrealized gain of $2,129 on all contracts at September 30, 2022. The Company’s derivative counterparties have strong credit ratings and as a result, the Company does not require collateral to facilitate transactions.

17

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The Company held the following contracts designated as hedging instruments as of September 30, 2022 and December 31, 2021:

| September 30, 2022
| Notional |  | Latest
| Amount |  | Maturity
Foreign exchange contracts - Canadian Dollars | $8,604 |  | February 2023
Foreign exchange contracts - Euros | € 13,370 |  | February 2023

| December 31, 2021
| Notional |  | Latest
| Amount |  | Maturity
Foreign exchange contracts - Canadian Dollars | $14,850 |  | February 2023
Foreign exchange contracts - Euros | € 20,104 |  | February 2023

For contracts that qualify as effective hedge instruments, the effective portion of gains and losses resulting from changes in fair value of the instruments are included in accumulated other comprehensive loss and reclassified to sales in the period the underlying hedged transaction is recognized in earnings. Gains (losses) of $1,218 and $201 were reclassified to sales during the three months ended September 30, 2022 and 2021, respectively, and $2,081 and $(542) were reclassified to sales during the nine months ended September 30, 2022 and 2021, respectively.

The following table presents the balance sheet classification and fair value of derivative instruments as of September 30, 2022 and December 31, 2021:

| Classification |  | September 30, 2022 |  | December 31, 2021
Derivative instruments in asset positions: |  |  |  |  |  |  |
Designated forward exchange contracts | Prepaid and other current assets |  | $ | 2,674 |  | $ | 491
Designated forward exchange contracts | Other long-term assets |  | $ | - |  | $ | 20
Derivative instruments in liability positions: |  |  |  |  |  |  |
Undesignated commodity derivative contracts | Accrued liabilities |  | $ | 545 |  | $ | -
Designated forward exchange contracts | Other long-term liabilities |  | $ | - |  | $ | 24

NOTE 9. ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive loss (“AOCI”) primarily consists of foreign currency translation adjustments and changes in our forward foreign exchange contracts. The following table sets forth the changes in AOCI, net of tax, for the three months ended September 30, 2022:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of June 30, 2022 | $ | (16,796) |  | $ | 899 |  | $ | (15,897)
Other comprehensive (loss) income before reclassifications |  | (11,386) |  |  | 1,203 |  |  | (10,183)
Amounts reclassified from other comprehensive income |  | - |  |  | (935) |  |  | (935)
Net current period other comprehensive (loss) income |  | (11,386) |  |  | 268 |  |  | (11,118)
Balance as of September 30, 2022 | $ | (28,182) |  | $ | 1,167 |  | $ | (27,015)

18

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The following table sets forth the changes in AOCI, net of tax, for the three months ended September 30, 2021:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of June 30, 2021 | $ | 759 |  | $ | 24 |  | $ | 783
Other comprehensive (loss) income before reclassifications |  | (8,933) |  |  | 422 |  |  | (8,511)
Amounts reclassified from other comprehensive income |  | - |  |  | (154) |  |  | (154)
Net current period other comprehensive (loss) income |  | (8,933) |  |  | 268 |  |  | (8,665)
Balance as of September 30, 2021 | $ | (8,174) |  | $ | 292 |  | $ | (7,882)

The following table sets forth the changes in AOCI, net of tax, for the nine months ended September 30, 2022:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of December 31, 2021 | $ | (5,241) |  | $ | 191 |  | $ | (5,050)
Other comprehensive (loss) income before reclassifications |  | (22,941) |  |  | 2,574 |  |  | (20,367)
Amounts reclassified from other comprehensive loss |  | - |  |  | (1,598) |  |  | (1,598)
Net current period other comprehensive (loss) income |  | (22,941) |  |  | 976 |  |  | (21,965)
Balance as of September 30, 2022 | $ | (28,182) |  | $ | 1,167 |  | $ | (27,015)

The following table sets forth the changes in AOCI, net of tax, for the nine months ended September 30, 2021:

| Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total
Balance as of December 31, 2020 | $ | 1,480 |  | $ | (980) |  | $ | 500
Other comprehensive (loss) income before reclassifications |  | (9,654) |  |  | 857 |  |  | (8,797)
Amounts reclassified from other comprehensive income |  | - |  |  | 415 |  |  | 415
Net current period other comprehensive (loss) income |  | (9,654) |  |  | 1,272 |  |  | (8,382)
Balance as of September 30, 2021 | $ | (8,174) |  | $ | 292 |  | $ | (7,882)

The effects on net income of amounts reclassified from unrealized gains on cash flow hedges for foreign exchange contracts for the three and nine months ended September 30, 2022 and 2021, were as follows:

| Gains (losses) reclassified from AOCI to the Condensed Consolidated Statements of Comprehensive (Loss) Income
| Three Months Ended |  | Nine Months Ended
Affected line item in the Condensed Consolidated Statements of Comprehensive (Loss) Income | September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Foreign exchange contracts: |  |  |  |  |  |  |  |  |  |  |
Sales | $ | 1,218 |  | $ | 201 |  | $ | 2,081 |  | $ | (542)
Less: Income tax expense (benefit) |  | 283 |  |  | 47 |  |  | 483 |  |  | (127)
Amount reclassified, net of tax | $ | 935 |  | $ | 154 |  | $ | 1,598 |  | $ | (415)
Total reclassifications from AOCI | $ | 935 |  | $ | 154 |  | $ | 1,598 |  | $ | (415)

19

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 10. FAIR VALUE MEASUREMENTS

We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, under a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1 - inputs to the valuation methodology are quoted market prices for identical assets or liabilities in active markets.

Level 2 - inputs to the valuation methodology include quoted prices in markets that are not active or model inputs that are

observable either directly or indirectly for substantially the full term of the asset or liability.

Level 3 - inputs to the valuation methodology are based on prices or valuation techniques that are unobservable.

Assets and liabilities measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021 were as follows:

| September 30, 2022
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 2,674 |  | $ | - |  | $ | 2,674
| $ | - |  | $ | 2,674 |  | $ | - |  | $ | 2,674
Liabilities |  |  |  |  |  |  |  |  |  |  |
Undesignated commodity derivative contracts | $ | 545 |  | $ | - |  | $ | - |  | $ | 545
Contingent consideration liabilities |  | - |  |  | - |  |  | 1,518 |  |  | 1,518
| $ | 545 |  | $ | - |  | $ | 1,518 |  | $ | 2,063
| December 31, 2021
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 511 |  | $ | - |  | $ | 511
| $ | - |  | $ | 511 |  | $ | - |  | $ | 511
Liabilities |  |  |  |  |  |  |  |  |  |  |
Designated forward exchange contracts | $ | - |  | $ | 24 |  | $ | - |  | $ | 24
Contingent consideration liabilities |  | - |  |  | - |  |  | 3,485 |  |  | 3,485
| $ | - |  | $ | 24 |  | $ | 3,485 |  | $ | 3,509

Derivative financial instruments are recorded at fair value based on current market pricing models. No nonrecurring fair value measurements existed at September 30, 2022 and December 31, 2021.

The Company estimated the fair value of contingent consideration liabilities primarily using a series of call options or other valuation methodologies. Significant unobservable inputs used in the valuation include discount rates ranging from 4.8% to 8.0%. Contingent consideration liabilities are remeasured at the estimated fair value at the end of each reporting period with the change in fair value recognized in contingent consideration expense in the accompanying condensed consolidated statements of comprehensive income for such period. We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements.

The net sales threshold required for the payment of the Rhino-Rack Contingent Consideration was not met during the measurement period ended June 30, 2022. The net sales threshold required for the payment of the 2022 portion of the MAXTRAX Contingent Consideration was met during the 2022 measurement period ended June 30, 2022. During the three months ended September 30, 2022, $AUD 3,125 was paid in cash in accordance with the MAXTRAX Purchase Agreement.

20

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The following table summarizes the changes in contingent consideration liabilities:

| Rhino-Rack |  | MAXTRAX |  | Total
Balance at December 31, 2021 | $ | 1,813 |  | $ | 1,672 |  | $ | 3,485
Fair value adjustments |  | (1,811) |  |  | 2,304 |  |  | 493
Contingent consideration payments |  | - |  |  | (2,148) |  |  | (2,148)
Impact of foreign currency exchange rates |  | (2) |  |  | (310) |  |  | (312)
Balance at September 30, 2022 | $ | - |  | $ | 1,518 |  | $ | 1,518

As the contingent consideration liabilities are remeasured to fair value each reporting period, significant increases or decreases in projected sales, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement. Our determination of fair value of the contingent consideration liabilities could change in future periods based on our ongoing evaluation of these significant unobservable inputs.

NOTE 11. STOCKHOLDERS’ EQUITY

On August 6, 2018, the Company announced that its Board of Directors approved the initiation of a quarterly cash dividend program of $0.025 per share of the Company’s common stock (the “Quarterly Cash Dividend”) or $0.10 per share on an annualized basis. The declaration and payment of future Quarterly Cash Dividends is subject to the discretion of and approval of the Company’s Board of Directors. On November 3, 2022, the Company announced that its Board of Directors approved the payment on November 25, 2022 of the Quarterly Cash Dividend of $0.025 to the record holders of shares of the Company’s common stock as of the close of business on November 14, 2022.

NOTE 12. EARNINGS PER SHARE

Basic earnings per share is computed by dividing earnings by the weighted average number of common shares outstanding during each period. Diluted earnings per share is computed by dividing earnings by the total of the weighted average number of shares of common stock outstanding during each period, plus the effect of dilutive outstanding stock options and unvested restricted stock grants. Potentially dilutive securities are excluded from the computation of diluted earnings per share if their effect is anti-dilutive to the loss from continuing operations.

The following table is a reconciliation of basic and diluted shares of common stock outstanding used in the calculation of earnings per share:

| Three Months Ended |  | Nine Months Ended
| September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Weighted average shares outstanding - basic |  | 37,369 |  |  | 33,800 |  |  | 37,256 |  |  | 32,159
Effect of dilutive stock awards |  | 2,061 |  |  | 2,364 |  |  | 2,246 |  |  | 1,885
Effect of dilutive deferred stock consideration for business acquisition |  | 150 |  |  | - |  |  | 192 |  |  | -
Weighted average shares outstanding - diluted |  | 39,580 |  |  | 36,164 |  |  | 39,694 |  |  | 34,044
Net income per share: |  |  |  |  |  |  |  |  |  |  |
Basic | $ | 0.07 |  | $ | 0.13 |  | $ | 0.32 |  | $ | 0.37
Diluted |  | 0.07 |  |  | 0.13 |  |  | 0.30 |  |  | 0.35

For the three months ended September 30, 2022 and 2021, equity awards of 1,713 and 1,000, respectively, and for the nine months ended September 30, 2022 and 2021, equity awards of 1,560 and 1,011, respectively, were excluded from the calculation of earnings per share for these periods as they were anti-dilutive.

21

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOTE 13. STOCK-BASED COMPENSATION PLAN

Under the Company’s current 2015 Stock Incentive Plan (the “2015 Plan”), the Company’s Board of Directors has flexibility to determine the type and amount of awards to be granted to eligible participants, who must be employees, directors, officers or consultants of the Company or its subsidiaries. The 2015 Plan allows for grants of incentive stock options, nonqualified stock options, restricted stock awards, stock appreciation rights, and restricted units. The aggregate number of shares of common stock that may be granted through awards under the 2015 Plan to any employee in any calendar year may not exceed 500 shares. The 2015 Plan will continue in effect until December 2025 unless terminated sooner.

Options Granted:

During the nine months ended September 30, 2022, the Company issued stock options for an aggregate of 440 shares under the 2015 Plan to directors and employees of the Company. Of the 440 options, 355 vest and become exercisable over a period of three years, 75 vest in four equal consecutive quarterly tranches from the date of grant and the remaining 10 vest immediately. All of the issued stock options expire ten years from the date of the grant.

For computing the fair value of the stock-based awards, the fair value of each option grant has been estimated as of the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Options Granted During the Nine Months Ended September 30, 2022

Number of options |  | 430 |  | 10
Option vesting period |  | 1 - 3 Years |  | Immediate
Grant price (per share) |  | $18.67 - $27.65 |  | $21.83
Dividend yield |  | 0.36% - 0.54% |  | 0.46%
Expected volatility (a) |  | 38.6% - 40.9% |  | 39.4%
Risk-free interest rate |  | 1.46% - 3.38% |  | 1.66%
Expected life (years) (b) |  | 5.31 - 6.01 |  | 5.50
Weighted average fair value (per share) |  | $7.82 - $10.41 |  | $8.03

(a)Expected volatility is based upon the Company’s historical volatility.

(b)The expected term was determined based upon the underlying terms of the awards and the category and employment history of employee award recipient.

The grant date fair value of the stock options granted during the nine months ended September 30, 2022 was $3,661, which will be recognized over the vesting period of the options.

Market Condition Restricted Shares Granted:

On March 4, 2022, the Company issued and granted to certain employees restricted stock awards of 700 restricted shares under the 2015 Plan, of which 700 restricted shares will vest if, on or before March 4, 2032, the Fair Market Value (as defined in the Plan) of the Company’s common stock shall have equaled or exceeded $50.00 per share for twenty consecutive trading days. For computing the fair value of the restricted shares with a market condition, the fair value of the restricted stock award grant has been estimated as of the date of grant using the Monte-Carlo pricing model with the following assumptions:

|  | March 4, 2022
Number issued |  | 700
Market condition vesting requirement |  | $50.00 stock price target
Price on date of grant (per share) |  | $21.83
Dividend yield |  | 0.46%
Expected volatility |  | 41.0%
Risk-free interest rate |  | 1.74%
Weighted average fair value (per share) |  | $15.37

Using these assumptions, the fair value of the market condition restricted stock awards granted on March 4, 2022, was approximately $10,761 and the expected term was 4.15 years.

22

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

The total non-cash stock compensation expense related to restricted stock, stock options and stock awards recorded by the Company for the three months ended September 30, 2022 and 2021 was $2,220 and $3,064, respectively, and for the nine months ended September 30, 2022 and 2021 was $9,142 and $6,414, respectively. For the three and nine months ended September 30, 2022 and 2021, the majority of stock-based compensation costs were classified as selling, general and administrative expenses.

As of September 30, 2022, there were 1,492 unvested stock options and unrecognized compensation cost of $5,862 related to unvested stock options, as well as 1,546 unvested restricted stock awards and unrecognized compensation costs of $9,919 related to unvested restricted stock awards.

NOTE 14. COMMITMENTS AND CONTINGENCIES

As a consumer goods manufacturer and distributor, the Company faces the risk of product liability and related lawsuits involving claims for substantial money damages, product recall actions and higher than anticipated rates of warranty returns or other returns of goods. The Company is therefore vulnerable to various personal injury and property damage lawsuits relating to its products and incidental to its business.

The Company is involved in various legal disputes and other legal proceedings that arise from time to time in the ordinary course of business. Anticipated costs related to l itigation matters are accrued when it is both probable that a liability has been incurred and the amount can be reasonably estimated. Based on currently available information, the Company does not believe that it is reasonably possible that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. There is a reasonable possibility of loss from contingencies in excess of the amounts accrued by the Company in the accompanying condensed consolidated balance sheets; however, the actual amounts of such possible losses cannot currently be reasonably estimated by the Company at this time. It is possible that, as additional information becomes available, the impact on the Company could have a different effect.

NOTE 15. INCOME TAXES

The Company’s U.S. federal statutory tax rate of 21% and its foreign operations have statutory tax rates of approximately 25% in Austria, 28% in New Zealand, and 30% in Australia.

The difference between the Company’s estimated effective tax rates of (3.1)% for the three months ended September 30, 2022, and the U.S. federal statutory tax rate of 21% was primarily due to the impact of discrete stock option windfall benefits in the third quarter of 2022. The difference between the Company’s estimated effective tax rates of 17.4% for the nine months ended September 30, 2022, and the U.S. federal statutory tax rate of 21% was primarily due to the impact of discrete stock option windfall benefits in the third quarter, partially offset by the impact of foreign earnings taxed at applicable statutory rates and permanent book to tax differences related to incentive stock options and officer compensation limitations.

As of December 31, 2021, the Company’s gross deferred tax asset was $38,184. The Company has recorded a valuation allowance of $4,378, resulting in a net deferred tax asset of $33,806, before deferred tax liabilities of $46,653. The Company has provided a valuation allowance against a portion of the deferred tax assets as of September 30, 2022 and December 31, 2021, because the ultimate realization of those assets did not meet the more-likely-than-not criteria. The majority of the Company’s deferred tax assets consist of NOLs for federal tax purposes. If a change in control were to occur, these could be limited under Section 382 of the Internal Revenue Code of 1986 (“Code”), as amended.

In assessing the realizability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible and net operating loss and credit carryforwards expire. The estimates and judgments associated with the Company’s valuation allowance on deferred tax assets are considered critical due to the amount of deferred tax assets recorded by the Company on its consolidated balance sheet and the judgment required in determining the Company’s future taxable income. The need for a valuation allowance is reassessed at each interim reporting period.

As of September 30, 2022, the Company had NOLs and research and experimentation credit for U.S. federal income tax purposes of $58,376 and $2,259, respectively. The Company believes its U.S. Federal NOLs will substantially offset its future U.S. Federal income taxes until expiration.

23

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

NOLs available to offset taxable income, subject to compliance with Section 382 of the Code, begin to expire based upon the following schedule:

Net Operating Loss Carryforward Expiration Dates
September 30, 2022
Expiration Dates December 31, |  | Net Operating Loss Amount
2022 |  | $ | 37,171
2023 |  |  | 5,712
2024 |  |  | 3,566
2025 and beyond |  |  | 11,927
Total |  | $ | 58,376

NOTE 16. SEGMENT INFORMATION

We operate our business structure within three segments. These segments are defined based on the internal financial reporting used by our chief operating decision maker to allocate resources and assess performance. Certain significant selling and general and administrative expenses are not allocated to the segments including non-cash stock compensation expense. Each segment is described below:

Our Outdoor segment, which includes Black Diamond Equipment, PIEPS, and SKINourishment, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. Our Outdoor segment offers a broad range of products including: high-performance, activity-based apparel (such as shells, insulation, midlayers, pants and logowear); rock-climbing footwear and equipment (such as carabiners, protection devices, harnesses, belay devices, helmets, and ice-climbing gear); technical backpacks and high-end day packs; trekking poles; headlamps and lanterns; gloves and mittens; and skincare and other sport-enhancing products. We also offer advanced skis, ski poles, ski skins, and snow safety products, including avalanche airbag systems, avalanche transceivers, shovels, and probes.

Our Precision Sport segment, which includes Sierra and Barnes, includes two iconic American manufacturers of a wide range of high-performance bullets and ammunition for both rifles and pistols. These bullets are used for precision target shooting, hunting and military and law enforcement purposes.

Our Adventure segment, which includes Rhino-Rack and MAXTRAX, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and a growing presence in the United States.

As noted above, the Company has a wide variety of technical outdoor equipment and lifestyle products that are sold to a variety of customers in multiple end markets. While there are multiple products sold, the terms and nature of revenue recognition policy is similar for all segments.

24

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Financial information for our segments, as well as revenue by geography, which the Company believes provides a meaningful depiction how the nature, timing and uncertainty of revenue are affected by economic factors, is as follows:

| Three Months Ended |  | Nine Months Ended
| September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Sales to external customers: |  |  |  |  |  |  |  |  |  |  |
Outdoor |  |  |  |  |  |  |  |  |  |  |
Domestic sales | $ | 27,446 |  | $ | 26,773 |  | $ | 80,368 |  | $ | 77,765
International sales |  | 35,430 |  |  | 32,256 |  |  | 86,634 |  |  | 77,952
Total Outdoor |  | 62,876 |  |  | 59,029 |  |  | 167,002 |  |  | 155,717
Precision Sport |  |  |  |  |  |  |  |  |  |  |
Domestic sales |  | 24,612 |  |  | 27,363 |  |  | 79,248 |  |  | 75,820
International sales |  | 9,595 |  |  | 2,954 |  |  | 23,264 |  |  | 6,449
Total Precision Sport |  | 34,207 |  |  | 30,317 |  |  | 102,512 |  |  | 82,269
Adventure |  |  |  |  |  |  |  |  |  |  |
Domestic sales |  | 3,482 |  |  | 7,123 |  |  | 22,304 |  |  | 7,123
International sales |  | 15,150 |  |  | 12,502 |  |  | 52,106 |  |  | 12,502
Total Adventure |  | 18,632 |  |  | 19,625 |  |  | 74,410 |  |  | 19,625
Total sales to external customers |  | 115,715 |  |  | 108,971 |  |  | 343,924 |  |  | 257,611
Segment operating income (loss): |  |  |  |  |  |  |  |  |  |  |
Outdoor |  | 5,853 |  |  | 5,939 |  |  | 9,212 |  |  | 10,041
Precision Sport |  | 9,936 |  |  | 10,441 |  |  | 33,951 |  |  | 26,420
Adventure |  | (3,736) |  |  | (3,014) |  |  | (968) |  |  | (3,014)
Total segment operating income |  | 12,053 |  |  | 13,366 |  |  | 42,195 |  |  | 33,447
Transaction costs |  | (858) |  |  | (8,147) |  |  | (2,880) |  |  | (9,272)
Contingent consideration expense |  | (104) |  |  | - |  |  | (493) |  |  | -
Corporate and other expenses |  | (6,207) |  |  | (5,163) |  |  | (19,444) |  |  | (16,363)
Interest expense, net |  | (2,216) |  |  | (1,476) |  |  | (5,060) |  |  | (1,926)
Income (loss) before income tax | $ | 2,668 |  | $ | (1,420) |  | $ | 14,318 |  | $ | 5,886

There were no intercompany sales between the Outdoor, Precision Sport, and Adventure segments for the periods presented.

Total assets by segment, as of September 30, 2022 and December 31, 2021, were as follows:

|  |  |  |  |  |  | September 30, 2022 |  | December 31, 2021
Outdoor |  |  |  |  |  |  | $ | 181,669 |  | $ | 166,751
Precision Sport |  |  |  |  |  |  |  | 153,812 |  |  | 142,549
Adventure |  |  |  |  |  |  |  | 266,340 |  |  | 298,364
Corporate |  |  |  |  |  |  |  | 26,120 |  |  | 24,163
|  |  |  |  |  |  | $ | 627,941 |  | $ | 631,827

25

CLARUS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

(Unaudited)

(in thousands, except per share amounts)

Capital expenditures, depreciation and amortization by segment is as follows.

| Three Months Ended |  | Nine Months Ended
| September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Capital expenditures: |  |  |  |  |  |  |  |  |  |  |
Outdoor | $ | 184 |  | $ | 819 |  | $ | 2,509 |  | $ | 2,091
Precision Sport |  | 1,024 |  |  | 957 |  |  | 2,246 |  |  | 2,910
Adventure |  | 936 |  |  | 578 |  |  | 1,461 |  |  | 578
Total capital expenditures | $ | 2,144 |  | $ | 2,354 |  | $ | 6,216 |  | $ | 5,579
Depreciation: |  |  |  |  |  |  |  |  |  |  |
Outdoor | $ | 794 |  | $ | 727 |  | $ | 2,440 |  | $ | 2,134
Precision Sport |  | 818 |  |  | 669 |  |  | 2,411 |  |  | 1,967
Adventure |  | 479 |  |  | 235 |  |  | 949 |  |  | 235
Total depreciation | $ | 2,091 |  | $ | 1,631 |  | $ | 5,800 |  | $ | 4,336
Amortization: |  |  |  |  |  |  |  |  |  |  |
Outdoor | $ | 248 |  | $ | 259 |  | $ | 753 |  | $ | 776
Precision Sport |  | 692 |  |  | 938 |  |  | 2,077 |  |  | 2,815
Adventure |  | 2,743 |  |  | 2,380 |  |  | 8,910 |  |  | 2,380
Total amortization | $ | 3,683 |  | $ | 3,577 |  | $ | 11,740 |  | $ | 5,971

26

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

Please note that in this Quarterly Report on Form 10-Q Clarus Corporation (which may be referred to as the “Company,” “Clarus,” “we,” “our” or “us”) may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements.

Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this Quarterly Report on Form 10-Q include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital and credit markets; the financial strength of the Company’s customers; the Company’s ability to implement its business strategy; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to the manufacture and sale of bullets and ammunition, and the possession and use of firearms and ammunition by our customers; the Company’s exposure to product liability or product warranty claims and other loss contingencies; disruptions and other impacts to the Company’s business, as a result of the COVID-19 global pandemic and government actions and restrictive measures implemented in response; stability of the Company’s manufacturing facilities and suppliers, as well as consumer demand for our products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact that global climate change trends may have on the Company and its suppliers and customers, increased focus on sustainability issues as a result of global climate change, the Company's ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, our information systems; the ability of our information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes; our ability to properly maintain, protect, repair or upgrade our information technology systems or information security systems, or problems with our transitioning to upgraded or replacement systems; the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; ongoing disruptions and delays in the shipping and transportation of our products due to port congestion, container ship availability and/or other logistical challenges; the impact of political unrest, natural disasters or other crises, terrorist acts, acts of war and/or military operations; our ability to utilize our net operating loss carryforwards; changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks; the Company’s ability to maintain a quarterly dividend; and any material differences in the actual financial results of the Rhino-Rack acquisition as compared with expectations, including the impact of the acquisition and any recognition of impairment or other charges relating to the acquisition on the Company’s future earnings per share. More information on potential factors that could affect the Company’s financial results is included from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. All forward-looking statements included in this Quarterly Report on Form 10-Q are based upon information available to the Company as of the date of this Quarterly Report on Form 10-Q, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q.

Overview

Headquartered in Salt Lake City, Utah, Clarus is a global leading designer, developer, manufacturer and distributor of best-in-class outdoor equipment and lifestyle products focused on the outdoor and consumer enthusiast markets. Our mission is to identify, acquire and grow outdoor “super fan” brands through our unique “innovate and accelerate” strategy. We define a “super fan” brand as a brand that creates the world’s pre-eminent, performance-defining product that the best-in-class user cannot live without. Each of our brands has a long history of continuous product innovation for core and everyday users alike. The Company’s products are principally sold globally under the Black Diamond®, Sierra®, Barnes®, Rhino-Rack® and MAXTRAX® brand names through outdoor specialty and online retailers, our own websites, distributors and original equipment manufacturers. Our portfolio of iconic brands is well-positioned for sustainable, long-term growth underpinned by powerful industry trends across the outdoor and adventure sport end markets.

One of the key elements of our sustained financial performance is our persistent focus on brand building through product initiatives. Our iconic brands are rooted in performance-defining technologies that enable our customers to have their best days outdoors. We have a long history of technical innovation and product development, backed by an extensive patent portfolio that continues to evolve and advance our markets. We currently employ approximately 120 engineers across the portfolio, focusing on enhancing our customers’

27

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

performance in the most critical moments. Our commitment to quality, rigorous safety, and ultimately best-in-class design is evidenced by outstanding industry recognition, as we have received numerous product awards across our portfolio of super fan brands.

Each of our brands represents a unique customer value proposition. Supported by six decades of proven innovation, Black Diamond, is an established global leader in high-performance, activity-based climbing, skiing, and technical mountain sports equipment. The brand is synonymous with premium performance, safety and reliability. Our Sierra and Barnes brands have been leading specialty manufacturers of bullets and ammunition for over 50 years. Since 1947, Sierra has been dedicated to manufacturing the highest-quality, most accurate bullets in the world for hunting and sport shooting enthusiasts. Barnes traces its history back to 1932, and since 1989 has manufactured technologically-advanced lead-free bullets and premium ammunition for hunters, range shooters, military and law enforcement professionals. Founded in 1992, our Rhino-Rack brand is a globally-recognized designer and distributor of highly-engineered automotive roof racks and accessories to enhance the outdoor enthusiast’s overlanding experience. Founded in 2005, our MAXTRAX brand offers high-quality overlanding and off-road vehicle recovery and extraction tracks for the overland and off-road market.

Clarus, incorporated in Delaware in 1991, acquired Black Diamond Equipment, Ltd. (“Black Diamond Equipment”) in May 2010 and changed its name to Black Diamond, Inc. in January 2011. In October 2012, we acquired PIEPS Holding GmbH and its subsidiaries (collectively, “PIEPS”). On August 14, 2017, the Company changed its name from Black Diamond, Inc. to Clarus Corporation and its stock ticker symbol from “BDE” to “CLAR” on the NASDAQ stock exchange.

On August 21, 2017, the Company acquired Sierra Bullets, L.L.C. (“Sierra”). On November 6, 2018, the Company acquired the assets of SKINourishment, Inc. (“SKINourishment”). On October 2, 2020, the Company completed the acquisition of certain assets and liabilities constituting the Barnes business (“Barnes”). On July 1, 2021, the Company completed the acquisition of Australia-based Rhino-Rack Holdings Pty Ltd (“Rhino-Rack”). On December 1, 2021, the Company completed the acquisition of Australia-based MaxTrax Australia Pty Ltd (“MAXTRAX”).

On August 6, 2018, the Company announced that its Board of Directors approved the initiation of a quarterly cash dividend program of $0.025 per share of the Company’s common stock (the “Quarterly Cash Dividend”) or $0.10 per share on an annualized basis. The declaration and payment of future Quarterly Cash Dividends is subject to the discretion of and approval of the Company’s Board of Directors. On November 3, 2022, the Company announced that its Board of Directors approved the payment on November 25, 2022 of the Quarterly Cash Dividend of $0.025 to the record holders of shares of the Company’s common stock as of the close of business on November 14, 2022.

Impact of COVID-19

The global outbreak of COVID-19 was declared a pandemic by the World Health Organization and a national emergency by each of the U.S., European, and Australian governments in March 2020, with governments world-wide implementing safety measures restricting travel and requiring citizen lockdowns and self-confinements for quarantining purposes. This has negatively affected the U.S., European, Australian and global economies, disrupted global supply chains, and resulted in significant transport restrictions and disruption of global financial markets.

The COVID-19 pandemic has significantly impacted the global supply chain, with restrictions and limitations on related activities causing disruption and delay, along with increased raw material, storage, and shipping costs. These disruptions and delays have strained domestic and international supply chains, which have affected and could continue to negatively affect the flow or availability of certain critical raw materials and finished good products that the Company relies upon. Furthermore, significantly increased demand from online sales channels, including our website, has impacted our logistical operations, including our fulfillment and shipping functions, which has resulted in periodic delays in the delivery of our products.

We expect a continued impact on the Company’s sales and profitability in future periods due to the ongoing impact of the pandemic. The duration of these trends and the magnitude of such impacts cannot be precisely estimated at this time, as they are affected by a number of factors (some of which are outside management’s control), including those presented in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2021.

Critical Accounting Policies and Use of Estimates

Management’s discussion of our financial condition and results of operations is based on the consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of the consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting

28

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

periods. Our critical accounting policies that require the use of estimates and assumptions were discussed in detail in our Annual Report on Form 10-K for the year ended December 31, 2021. We base our estimates on historical experience and other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.

There have been no significant changes to our critical accounting policies as described in our Annual Report on Form 10-K for the year ended December 31, 2021.

Accounting Pronouncements Issued Not Yet Adopted

None

‎

29

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Results of Operations

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021

The following presents a discussion of operations for the three months ended September 30, 2022, compared with the three months ended September 30, 2021.

| Three Months Ended
| September 30, 2022 |  | September 30, 2021
Sales |  |  |  |  |
Domestic sales | $ | 55,540 |  | $ | 61,259
International sales |  | 60,175 |  |  | 47,712
Total sales |  | 115,715 |  |  | 108,971
Cost of goods sold |  | 76,291 |  |  | 69,792
Gross profit |  | 39,424 |  |  | 39,179
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 32,340 |  |  | 31,314
Transaction costs |  | 858 |  |  | 8,147
Contingent consideration expense |  | 104 |  |  | -
Total operating expenses |  | 33,302 |  |  | 39,461
Operating income (loss) |  | 6,122 |  |  | (282)
Other expense |  |  |  |  |
Interest expense, net |  | (2,216) |  |  | (1,476)
Other, net |  | (1,238) |  |  | 338
Total other expense, net |  | (3,454) |  |  | (1,138)
Income (loss) before income tax |  | 2,668 |  |  | (1,420)
Income tax benefit |  | (83) |  |  | (5,950)
Net income | $ | 2,751 |  | $ | 4,530

Sales

Total sales increased $6,744, or 6.2%, to $115,715, during the three months ended September 30, 2022, compared to total sales of $108,971 during the three months ended September 30, 2021. The increase in sales was primarily attributable to an increase in sales at the Outdoor and Precision Sport segments of $6,208 and $3,890, respectively. Additionally, there was an increase in sales of $3,676 from the inclusion of MAXTRAX in the current period. This was partially offset by a decrease in sales at Rhino-Rack of $3,743. Sales in the Outdoor segment were partially offset by a decrease in sales of $2,361, and sales at Rhino-Rack were further reduced by $926, due to the strengthening of the U.S. dollar against foreign currencies during the three months ended September 30, 2022, compared to the prior period.

Domestic sales decreased $5,719, or 9.3%, to $55,540 during the three months ended September 30, 2022, compared to domestic sales of $61,259 during the three months ended September 30, 2021. The decrease in sales was primarily attributable to a decrease in sales at Rhino-Rack of $3,877. Additionally, there was a decrease in sales at the Precision Sport segment of $2,751. This was partially offset by an increase in sales at the Outdoor segment during the period of $673 as well as an increase in sales of $236 from the inclusion of MAXTRAX.

International sales increased $12,463, or 26.1%, to $60,175 during the three months ended September 30, 2022, compared to international sales of $47,712 during the three months ended September 30, 2021. The increase in sales was primarily attributable to an increase in sales at the Precision Sport and Outdoor segments of $6,641 and $5,535, respectively. Additionally, there was an increase in

30

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

sales of $3,440 from the inclusion of MAXTRAX in the current period, and an increase in sales at Rhino-Rack of $134. Sales in the Outdoor segment and Rhino-Rack were partially offset by a decrease in sales of $2,361 and $926, respectively, due to the strengthening of the U.S. dollar against foreign currencies during the three months ended September 30, 2022, compared to the prior period.

Cost of Goods Sold

Cost of goods sold increased $6,499, or 9.3%, to $76,291 during the three months ended September 30, 2022, compared to cost of goods sold of $69,792 during the three months ended September 30, 2021. The increase in cost of goods sold was primarily attributable to an increase in the number of units sold.

Gross Profit

Gross profit increased $245, or 0.6%, to $39,424 during the three months ended September 30, 2022, compared to gross profit of $39,179 during the three months ended September 30, 2021. Gross margin was 34.1% during the three months ended September 30, 2022, compared to a gross margin of 36.0% during the three months ended September 30, 2021. Improvements in channel and product mix were completely offset by higher freight costs at the Outdoor and Adventure segments as well as unfavorable foreign exchange impacts due to the strengthening of the U.S. dollar against foreign currencies during the three months ended September 30, 2022. Gross margin during the three months ended September 30, 2021 was negatively impacted by the $3,099 Rhino-Rack fair value inventory charge due to purchase accounting.

Selling, General and Administrative

Selling, general, and administrative expenses increased $1,026, or 3.3%, to $32,340 during the three months ended September 30, 2022, compared to selling, general and administrative expenses of $31,314 during the three months ended September 30, 2021. The increase is primarily due to the inclusion of MAXTRAX in the current period, which contributed $1,185 in selling, general and administrative expenses, as well as increases in investments in retail and direct-to-consumer initiatives at the Outdoor segment. The increase was partially offset by a decrease in stock compensation of $844 during the three months ended September 30, 2022 compared to the prior year. Additionally, the Company incurred higher Corporate costs of $310 primarily related to professional fees during the three months ended September 30, 2022 compared to the prior year. The increase in professional fees includes expenses incurred in connection with a lawsuit filed by the Company on September 19, 2022, in the U.S. District Court for the Southern District of New York against HAP Trading, LLC and Mr. Harsh A. Padia to seek to disgorge profits from transactions in the Company’s common stock and related derivative securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended.

Transaction Costs

Transaction expense decreased to $858 during the three months ended September 30, 2022, compared to transaction costs of $8,147 during the three months ended September 30, 2021, which consisted of expenses related to the Company’s various acquisition efforts.

Contingent Consideration Expense

Contingent consideration expense increased to $104 during the three months ended September 30, 2022, compared to $0 contingent consideration expense during the three months ended September 30, 2021, which consisted of changes in estimated fair value of contingent consideration liabilities.

Interest Expense, net

Interest expense, net increased to $2,216 during the three months ended September 30, 2022, compared to interest expense, net of $1,476 during the three months ended September 30, 2021. The increase in interest expense recognized during the three months ended September 30, 2022 was primarily associated with the increase in the average outstanding debt amounts during the period compared to the prior year and the recording of certain debt issuance costs.

Other, net

Other, net, decreased by $1,576, or 466.3%, to $1,238 during the three months ended September 30, 2022, compared to other, net income of $338 during the three months ended September 30, 2021. The change in other, net, was primarily attributable to an increase in remeasurement losses recognized on the Company’s foreign denominated accounts receivable and accounts payable as well as changes on mark-to-market adjustments on non-hedged commodity derivative contracts during the three months ended September 30, 2022 and non-hedged foreign currency contracts during the three months ended September 30, 2021.

31

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Income Taxes

Income tax benefit changed by $5,867, or 98.6%, to $83 during the three months ended September 30, 2022, compared to income tax benefit of $5,950 during the same period in 2021. Our effective income tax rate was a benefit of 3.1% for the three months ended September 30, 2022, and differed compared to the statutory tax rates primarily due to the impact of discrete stock option windfall benefits in the third quarter. For the three months ended September 30, 2021, our effective income tax rate was a benefit of 419.0% and differed compared to the statutory tax rates due to a release of a partial valuation allowance of the deferred tax assets and a discrete charge recorded during the period.

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021

The following presents a discussion of operations for the nine months ended September 30, 2022, compared with the nine months ended September 30, 2021.

| Nine Months Ended
| September 30, 2022 |  | September 30, 2021
Sales |  |  |  |  |
Domestic sales | $ | 181,920 |  | $ | 160,708
International sales |  | 162,004 |  |  | 96,903
Total sales |  | 343,924 |  |  | 257,611
Cost of goods sold |  | 216,566 |  |  | 163,361
Gross profit |  | 127,358 |  |  | 94,250
Operating expenses |  |  |  |  |
Selling, general and administrative |  | 101,959 |  |  | 72,903
Transaction costs |  | 2,880 |  |  | 9,272
Contingent consideration expense |  | 493 |  |  | -
Total operating expenses |  | 105,332 |  |  | 82,175
Operating income |  | 22,026 |  |  | 12,075
Other expense |  |  |  |  |
Interest expense, net |  | (5,060) |  |  | (1,926)
Other, net |  | (2,648) |  |  | (4,263)
Total other expense, net |  | (7,708) |  |  | (6,189)
Income before income tax |  | 14,318 |  |  | 5,886
Income tax expense (benefit) |  | 2,494 |  |  | (6,161)
Net income | $ | 11,824 |  | $ | 12,047

Sales

Total sales increased $86,313, or 33.5%, to $343,924, during the nine months ended September 30, 2022, compared to total sales of $257,611 during the nine months ended September 30, 2021. The increase in sales was primarily attributable to an increase in sales at Rhino-Rack during the period of $43,561. Additionally, there was an increase in sales at the Precision Sport and Outdoor segments of $20,243 and $15,590, respectively, as well as an increase in sales of $12,150 from the inclusion of MAXTRAX in the current period. Sales in the Outdoor segment and Rhino-Rack were partially offset by a decrease in sales of $4,305 and $926, respectively, due to the strengthening of the U.S. dollar against foreign currencies during the nine months ended September 30, 2022, compared to the prior period.

32

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Domestic sales increased $21,212, or 13.2%, to $181,920 during the nine months ended September 30, 2022, compared to domestic sales of $160,708 during the nine months ended September 30, 2021. The increase in sales was primarily attributable to an increase in sales at Rhino-Rack during the period of $12,293. Additionally, there was an increase in sales at the Precision Sport segment of $3,428, an increase in sales of $2,888 from the inclusion of MAXTRAX in the current period, and an increase in sales at the Outdoor segment of $2,603.

International sales increased $65,101, or 67.2%, to $162,004 during the nine months ended September 30, 2022, compared to international sales of $96,903 during the nine months ended September 30, 2021. The increase in sales was primarily attributable to an increase in sales at Rhino-Rack during the period of $31,268. Additionally, there was an increase in sales at the Precision Sport and Outdoor segments of $16,815 and $12,987, respectively, as well as an increase in sales of $9,262 from the inclusion of MAXTRAX in the current period. Sales in the Outdoor segment and Rhino-Rack were partially offset by a decrease in sales of $4,305 and $926, respectively, due to the strengthening of the U.S. dollar against foreign currencies during the nine months ended September 30, 2022, compared to the prior period.

Cost of Goods Sold

Cost of goods sold increased $53,205, or 32.6%, to $216,566 during the nine months ended September 30, 2022, compared to cost of goods sold of $163,361 during the nine months ended September 30, 2021. The increase in cost of goods sold was primarily attributable to an increase in the number of units sold.

Gross Profit

Gross profit increased $33,108, or 35.1%, to $127,358 during the nine months ended September 30, 2022, compared to gross profit of $94,250 during the nine months ended September 30, 2021. Gross margin was 37.0% during the nine months ended September 30, 2022, compared to a gross margin of 36.6% during the nine months ended September 30, 2021. Gross margin during the nine months ended September 30, 2022, increased compared to the prior year due to a favorable product mix from higher margin products and from the inclusion of Rhino-Rack and MAXTRAX in the current period. This increase was partially offset by the $269 MAXTRAX fair value inventory charge due to purchase accounting during the nine months ended September 30, 2022 as well as unfavorable foreign exchange impacts due to the strengthening of the U.S. dollar against foreign currencies. Gross margin during the nine months ended September 30, 2021 was negatively impacted by the $3,460 Rhino-Rack and Barnes fair value inventory charge due to purchase accounting.

Selling, General and Administrative

Selling, general, and administrative expenses increased $29,056, or 39.9%, to $101,959 during the nine months ended September 30, 2022, compared to selling, general and administrative expenses of $72,903 during the nine months ended September 30, 2021. The increase in selling, general and administrative expenses is primarily due to the inclusion of Rhino-Rack and MAXTRAX, which contributed $16,634 and $3,716, respectively. Additionally, the Company incurred higher Corporate costs of $1,965 primarily related to payroll and professional fees along with an increase of stock compensation of $2,728 during the nine months ended September 30, 2022 compared to the prior year. The remaining increase was primarily attributable to the Company’s investments in retail and direct-to-consumer initiatives at the Outdoor segment.

Transaction Costs

Transaction expense decreased to $2,880 during the nine months ended September 30, 2022, compared to transaction costs of $9,272 during the nine months ended September 30, 2021, which consisted of expenses related to the Company’s various acquisition efforts.

Contingent Consideration Expense

Contingent consideration expense increased to $493 during the nine months ended September 30, 2022, compared to $0 contingent consideration expense during the nine months ended September 30, 2021, which consisted of changes in estimated fair value of contingent consideration liabilities.

Interest Expense, net

Interest expense, net increased to $5,060 during the nine months ended September 30, 2022, compared to interest expense, net of $1,926 during the nine months ended September 30, 2021. The increase in interest expense recognized during the nine months ended September

33

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

30, 2022 was primarily associated with the increase in the average outstanding debt amounts during the period compared to the prior year and the recording of certain debt issuance costs.

Other, net

Other, net changed by $1,615, or 37.9%, to $2,648 during the nine months ended September 30, 2022, compared to other, net of $4,263 during the nine months ended September 30, 2021. The change in other, net, was primarily attributable to changes on mark-to-market adjustments on non-hedged commodity derivative contracts during the nine months ended September 30, 2022 and non-hedged foreign currency contracts during the nine months ended September 30, 2021. The change was partially offset by an increase in remeasurement losses recognized on the Company’s foreign denominated accounts receivable and accounts payable.

Income Taxes

Income tax expense changed by $8,655, or -140.5%, to an expense of $2,494 during the nine months ended September 30, 2022, compared to a benefit of $6,161 during the same period in 2021. Our effective income tax rate was 17.4% for the nine months ended September 30, 2022, and differed compared to the statutory tax rates primarily due to the impact of discrete stock option windfall benefits in the third quarter, partially offset by the impact of foreign earnings taxed at applicable statutory rates and permanent book to tax differences related to incentive stock options and officer compensation limitations. For the nine months ended September 30, 2021, our effective income tax rate was a benefit of 104.7% and differed compared to the statutory tax rates due to a release of a partial valuation allowance of the deferred tax assets and a discrete charge recorded during the period.

Liquidity and Capital Resources

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021

Our primary ongoing funding requirements are for working capital, expansion of our operations (both organically and through acquisitions) and general corporate needs, as well as investing activities associated with the various brands. We plan to fund these activities through a combination of our future operating cash flows and revolving credit facility which had approximately $110,000 available to borrow at September 30, 2022, while maintaining compliance with the consolidated total leverage ratio per the Restated Credit Agreement of 3.75 to 1. We believe that our liquidity requirements and contractual obligations for at least the next 12 months will be adequately covered by cash provided by operations and our existing revolving credit facility. Additionally, long-term contractual obligations are also currently expected to be funded from cash from operations and availability under our existing credit facilities. For additional information regarding the Company’s existing credit facilities, see the section titled “Credit Agreement” below.

At September 30, 2022, we had total cash of $10,365, compared to a cash balance of $19,465 at December 31, 2021. At September 30, 2022, the Company had $5,091 of the $10,365 in cash held by foreign entities, of which $3,672 is considered permanently reinvested.

The following presents a discussion of cash flows for the condensed consolidated nine months ended September 30, 2022 compared with the condensed consolidated nine months ended September 30, 2021.

| Nine Months Ended
| September 30, 2022 |  | September 30, 2021
Net cash used in operating activities | $ | (17,746) |  | $ | (17,101)
Net cash used in investing activities |  | (5,778) |  |  | (141,181)
Net cash provided by financing activities |  | 15,327 |  |  | 151,041
Effect of foreign exchange rates on cash |  | (903) |  |  | (378)
Change in cash |  | (9,100) |  |  | (7,619)
Cash, beginning of year |  | 19,465 |  |  | 17,789
Cash, end of period | $ | 10,365 |  | $ | 10,170

Net Cash From Operating Activities

Net cash used in operating activities was $17,476 during the nine months ended September 30, 2022, compared to net cash used in operating activities of $17,101 during the nine months ended September 30, 2021. The change in net cash used in operating activities

34

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

during 2022 is primarily due to an increase in working capital of $18,571, partially offset by increases in depreciation and amortization expenses, as well as stock compensation during the nine months ended September 30, 2022, compared to the same period in 2021.

Free cash flow, defined as net cash (used in) provided by operating activities less capital expenditures, of ($23,962) was used during the nine months ended September 30, 2022 compared to ($22,680) used during the same period in 2021. The Company believes that the non-GAAP measure, free cash flow, provides an understanding of the capital required by the Company to expand its asset base. A reconciliation of free cash flows to comparable GAAP financial measures is set forth below:

| Nine Months Ended
| September 30, 2022 |  | September 30, 2021
Net cash used in operating activities | $ | (17,746) |  | $ | (17,101)
Purchase of property and equipment |  | (6,216) |  |  | (5,579)
Free cash flow | $ | (23,962) |  | $ | (22,680)

Net Cash From Investing Activities

Net cash used in investing activities was $5,778 during the nine months ended September 30, 2022, compared to $141,181 during the nine months ended September 30, 2021. The decrease in cash used during the nine months ended September 30, 2022 is due to the acquisition of Rhino-Rack during the nine months ended September 30, 2021, partially offset by an increase in purchases of property and equipment, compared to the same period in 2021.

Net Cash From Financing Activities

Net cash provided by financing activities was $15,327 during the nine months ended September 30, 2022, compared to net cash provided by financing activities of $151,041 during the nine months ended September 30, 2021. The decrease in cash provided during the nine months ended September 30, 2022, compared to the same period in 2021 was primarily due to a decrease in net proceeds to the revolving line of credit and term loan and an increase in purchases of treasury stock.

Net Operating Loss

As of September 30, 2022, the Company had net operating loss carryforwards (“NOLs”) and research and experimentation credit for U.S. federal income tax purposes of $58,376 and $2,259, respectively. The Company believes its U.S. Federal NOLs will substantially offset its future U.S. Federal income taxes until expiration. The Company has $58,376 of NOLs, of which, $37,171 expire on December 31, 2022. These NOLs are subject to compliance with Section 382 of the Internal Revenue Code of 1986, as amended.

As of December 31, 2021, the Company’s gross deferred tax asset was $38,184. The Company has recorded a valuation allowance of $4,378, resulting in a net deferred tax asset of $33,806, before deferred tax liabilities of $46,653. The Company has provided a valuation allowance against a portion of the net deferred tax assets as of December 31, 2021, because the ultimate realization of those assets does not meet the more-likely-than-not criteria. The majority of the Company’s deferred tax assets consist of net operating loss carryforwards for federal tax purposes. If a change in control were to occur, these could be limited under Section 382 of the Internal Revenue Code of 1986 (“Code”), as amended.

Credit Agreement

As of September 30, 2022, the Company had drawn approximately $44,688 of the $300,000 revolving loan commitment that was available for borrowing under the Restated Credit Agreement (as defined below), and $121,875 was outstanding under the term loan commitment. As of September 30, 2022, the interest rates on the revolving loan and term loan commitments were approximately 5.0%. The Company was in compliance with the debt covenants set forth in the Restated Credit Agreement as of September 30, 2022.

On April 18, 2022 (the “Effective Date”), the Company, Black Diamond Retail, Inc., Black Diamond Retail – Alaska, LLC, Sierra Bullets, L.L.C., SKINourishment, LLC, Black Diamond Retail – Colorado, LLC, Black Diamond Retail – Montana, LLC, Black Diamond Retail – Wyoming, LLC, Barnes Bullets-Mona, LLC, Black Diamond Retail – Oregon, LLC, Black Diamond Retail – Vermont, LLC (collectively with the Company, the “Borrowers”) and the other loan parties party thereto (together with the Borrowers, each a “Loan Party”, and collectively, the “Loan Parties”) entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”) and the lenders party thereto (the “Restated Credit Agreement”) pursuant to which the existing Credit Agreement, dated as of May 3, 2019 (as amended prior to the Effective Date, the “Existing Credit

35

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

Agreement”) by and among the Company, the lenders and loan parties from time to time party thereto and the Administrative Agent was amended and restated in its entirety. Each of the Loan Parties, other than the Company, is a direct or indirect subsidiary of the Company.

The Restated Credit Agreement provides for borrowings of up to $300,000 under a secured revolving credit facility (the “Revolving Loans”) (including up to $5,000 for letters of credit), and borrowings of up to $125,000 under a secured term loan facility (the “Term Loans”). The Restated Credit Agreement also permits the Borrowers, subject to certain requirements, to arrange with lenders for an aggregate of up to $175,000 of additional revolving and/or term loan commitments (both of which are currently uncommitted), for potential aggregate revolving and term loan commitments under the Restated Credit Agreement of up to $600,000. The proceeds of loans made under the Restated Credit Agreement may be used for working capital and general corporate purposes, including acquisitions permitted under the Restated Credit Agreement. The Restated Credit Agreement matures on April 18, 2027 (the “Maturity Date”), at which time the revolving commitments thereunder will terminate and all outstanding Revolving Loans and Term Loans, together with all accrued and unpaid interest thereon, must be repaid.

The Term Loans were fully drawn on the Effective Date and cannot be reborrowed. The Restated Credit Agreement provides for quarterly amortization payments of the Term Loans on the last business day of each March, June, September and December, commencing on June 30, 2022. Through and including the payment due on March 31, 2023, the scheduled amortization payment is $1,563 per quarter, and each scheduled amortization payment due thereafter through the Maturity Date is $3,125 per quarter.

The Borrowers may elect to have the Revolving Loans and Term Loans under the Restated Credit Agreement bear interest at an applicable rate plus either:

(i) in the case of alternate base rate borrowings, a rate per annum generally equal to the greatest of:

| (a) | the prime rate in effect on such day;

| (b) | 0.50% plus the greater of the Federal Reserve Bank of New York’s effective federal funds rate or the Federal Reserve Bank of New York’s overnight bank funding rate in effect on such day; and

| (c) | 1.00% plus the adjusted term SOFR rate for a 1-month interest period;

provided that, in certain circumstances where the alternate base rate is being used as an alternate rate of interest, the alternate base rate shall be determined only according to (a) and (b), and shall be subject to a 1.00% floor; or

(ii) in the case of term benchmark borrowings, a rate per annum as follows:

| (a) | for borrowings denominated in U.S. Dollars, the term SOFR rate (based on one, three or six-month interest periods) plus 0.10%, subject to a 0.00% floor; or

| (b) | for borrowings denominated in a Foreign Currency, the applicable rate for such Foreign Currency set forth in the Restated Credit Agreement.

The applicable rate for these borrowings will range from 0.50% to 1.625% per annum, in the case of alternate base rate borrowings, and 1.50% to 2.625% per annum, in the case of term benchmark borrowings. The applicable rate was initially 0.875% per annum, in the case of alternate base rate borrowings, and 1.875% per annum, in the case of term benchmark borrowings, however, these initial applicable rates may be adjusted from time to time based upon the level of the Company’s consolidated total leverage ratio, which is more fully discussed in the Restated Credit Agreement. If one or more of the above interest rates are not determinable, or under certain other circumstances set forth in the Restated Credit Agreement, a substitute or alternative interest rate may apply under the Restated Credit Agreement.

The Restated Credit Agreement also requires the Borrowers to pay a commitment fee on the unused portion of the revolving loan commitments. Such commitment fee will range between 0.15% and 0.30% per annum, and is also based upon the level of the Company’s consolidated total leverage ratio, which is more fully discussed in the Restated Credit Agreement. The Company is also obligated to pay other customary closing fees, arrangement fees, administration fees and letter of credit fees for a credit facility of this size and type.

The Restated Credit Agreement contains customary affirmative and negative covenants, including limitations on the ability of the Company and its subsidiaries to perform the following, subject to certain customary exceptions, qualifications and “baskets”: (i) incur additional debt; (ii) create liens; (iii) engage in mergers, consolidations, certain divisions, liquidations or dissolutions other than in

36

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

certain permitted instances as described in the Restated Credit Agreement; (iv) substantially change the business conducted by the Company and its subsidiaries; (v) make certain investments, loans, advances, guarantees and acquisitions other than in certain permitted instances as described in the Restated Credit Agreement; (vi) sell assets; (vii) pay dividends or make distributions or other restricted payments if certain conditions in the Restated Credit Agreement are not fulfilled; (viii) prepay other indebtedness; (ix) engage in certain transactions with affiliates; (x) enter into agreements that restrict dividends from subsidiaries or the ability of subsidiaries to grant liens upon their assets; (xi) amend certain charter documents and material agreements governing subordinated indebtedness; (xii) permit the consolidated total leverage ratio, which is to be determined for each quarter end on a trailing twelve month basis, from exceeding a limit of 3.75 to 1, provided, that, subject to certain terms and conditions set forth in the Restated Credit Agreement, so long as no Event of Default (as defined in the Restated Credit Agreement) exists at such time or would result therefrom, the Company may elect to increase the maximum consolidated total leverage ratio permitted under the Restated Credit Agreement to 4.25:1.00 for a period of four consecutive fiscal quarters in connection with any acquisition permitted under the Restated Credit Agreement for which the aggregate consideration is greater than or equal to $60,000; and (xiii) permit the consolidated fixed charge coverage ratio, which is to be determined for each quarter end on a trailing twelve month basis, to be less than 1.25 to 1.

The Restated Credit Agreement also contains customary events of default, including, but not limited to: (i) failure to pay amounts due under the Restated Credit Agreement; (ii) materially incorrect representations and warranties; (iii) failure to comply with covenants; (iv) change of control; and (v) default under other indebtedness aggregating at least $3,000.

The obligations of each Loan Party under the Restated Credit Agreement are guaranteed by each other Loan Party. All obligations under the Restated Credit Agreement, and the guarantees of those obligations (as well as banking services obligations and certain swap agreements), are secured by pledges and liens on 100% of the equity interests of domestic subsidiaries, either 100% or 65% of the equity interests of certain foreign subsidiaries, and the accounts receivable, inventory, intellectual property and certain real property or other assets of the Loan Parties pursuant to (i) a Pledge and Security Agreement, dated as of May 3, 2019, by and among certain of the Loan Parties and the Administrative Agent (as amended from time to time prior to the Effective Date, the “PSA”), (ii) a General Security Deed, dated as of August 30, 2021, by and among certain of the Loan Parties and the Administrative Agent (the “Oscar GSD”), (iii) a General Security Deed, dated as of January 31, 2022, by and among certain of the Loan Parties and the Administrative Agent (the “Simpson GSD”) or (iv) a mortgage or other applicable security agreement or instrument. Each of the PSA, the Oscar GSD and the Simpson GSD was reaffirmed by the Loan Parties on the Effective Date pursuant to a Reaffirmation Agreement dated as of the Effective Date by and among the Administrative Agent and the Loan Parties (the “Reaffirmation Agreement”) pursuant to which each Loan Party ratified and reaffirmed its obligations to the Lenders in connection with entering into the Restated Credit Agreement.

Off-Balance Sheet Arrangements

We do not engage in any transactions or have relationships or other arrangements with unconsolidated entities. These include special purpose and similar entities or other off-balance sheet arrangements. We also do not engage in energy, weather or other commodity-based contracts.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There has not been any material change in the market risk disclosure contained in our Annual Report on Form 10-K for the year ended December 31, 2021.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company’s management carried out an evaluation, under the supervision and with the participation of the Company’s Executive Chairman and Chief Financial Officer, its principal executive officer and principal financial officer, respectively, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15I and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of September 30, 2022, pursuant to Exchange Act Rule 13a-15. Such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company is accumulated and communicated to the appropriate management on a basis that permits timely decisions regarding disclosure. Based upon that evaluation, the Company’s Executive Chairman and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of September 30, 2022, were effective.

On December 1, 2021, the Company completed the acquisition of Australia-based MaxTrax Australia Pty Ltd (“MAXTRAX”). Management excluded MAXTRAX from its assessment of the effectiveness of the Company’s internal control over financial reporting as of September 30, 2022.

37

CLARUS CORPORATION

MANAGEMENT DISCUSSION AND ANALYSIS

(in thousands, except per share amounts)

## Changes in Internal Control over Financial Reporting

The Company acquired MAXTRAX on December 1, 2021. The Company is currently in the process of integrating the internal controls over financial reporting at MAXTRAX. Except for the continued integration of MAXTRAX, there has been no change in our internal control over financial reporting that occurred during the nine months ended September 30, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

38

CLARUS CORPORATION

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDIN GS

Legal Proceedings

The Company is involved in various legal disputes and other legal proceedings that arise from time to time in the ordinary course of business. Based on currently available information, the Company does not believe that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. It is possible that, as additional information becomes available, the impact on the Company of an adverse determination could have a different effect.

Litigation

The Company is involved in various lawsuits arising from time to time that the Company considers ordinary routine litigation incidental to its business. Amounts accrued for litigation matters represent the anticipated costs (damages and/or settlement amounts) in connection with pending litigation and claims and related anticipated legal fees for defending such actions, which legal fees are expensed as incurred. The costs are accrued when it is both probable that a liability has been incurred and the amount can be reasonably estimated. The accruals are based upon the Company’s assessment, after consultation with counsel (if deemed appropriate), of probable loss based on the facts and circumstances of each case, the legal issues involved, the nature of the claim made, the nature of the damages sought and any relevant information about the plaintiffs and other significant factors that vary by case. When it is not possible to estimate a specific expected cost to be incurred, the Company evaluates the range of probable loss and records the minimum end of the range. Based on currently available information, the Company does not believe that it is reasonably possible that the disposition of any of the legal disputes the Company or its subsidiaries is currently involved in will have a material adverse effect upon the Company’s consolidated financial condition, results of operations or cash flows. There is a reasonable possibility of loss from contingencies in excess of the amounts accrued by the Company in the accompanying condensed consolidated balance sheets; however, the actual amounts of such possible losses cannot currently be reasonably estimated by the Company at this time. It is possible that, as additional information becomes available, the impact on the Company could have a different effect.

Product Liability

As a consumer goods manufacturer and distributor, the Company faces the risk of product liability and related lawsuits involving claims for substantial money damages, product recall actions and higher than anticipated rates of warranty returns or other returns of goods. The Company is therefore vulnerable to various personal injury and property damage lawsuits relating to its products and incidental to its business.

Based on current information, there are no pending product liability claims and lawsuits of the Company, which the Company believes in the aggregate, will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 1A. RISK FACTORS

Except for the risk factors discussed below, there have been no material changes in our risk factors from those disclosed in Part I, Item 1A. of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

We may be required subsequently to take write downs or write-offs, restructuring, and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our stock price, which could cause you to lose some or all of your investment.

In connection with our general growth strategy of acquiring businesses and assets, we may be forced to write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in us reporting losses. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our common stock.

39

CLARUS CORPORATION

ITEM 2. UNREGISTERED SALES OF EQU ITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities

The Company did not sell any securities during the quarter ended September 30, 2022 that were not registered under the Securities Act of 1933, as amended.

Issuer Repurchases of Equity Securities

On August 1, 2022, the Company announced that its Board of Directors had terminated its $30,000,000 share repurchase program, which still had $10,793,587 available, replacing it with a new stock repurchase program that allows the repurchase of up to $50,000,000 of the Company’s outstanding common stock. During the third quarter of 2022, the Company purchased 527,277 shares of the Company’s common stock for $7,170,783 under the Company’s authorized stock repurchase program.

|  |  |  |  |  |  |  | Total Number of Shares |  | Maximum Dollar Value
|  |  |  |  |  |  |  | Purchased as Part of |  | of Shares that May Yet
|  | Total Number of |  | Average Price Paid |  | Publicly Announced |  | Be Purchased Under
|  | Shares Purchased |  | per Share |  | Plans or Programs |  | the Plans or Programs
Period |  |  |  |  |  |  |  |  |  |  |  |
July 1 to 31, 2022 |  |  | - |  | $ | - |  |  | - |  | $ | 10,793,587
August 1 to 31, 2022 |  |  | - |  | $ | - |  |  | - |  | $ | 50,000,000
September 1 to 30, 2022 |  |  | 527,277 |  | $ | 13.60 |  |  | 527,277 |  | $ | 42,829,217
Total |  |  | 527,277 |  |  |  |  |  |  |  |  |

‎

40

CLARUS CORPORATION

ITEM 6. EXHIBITS

Exhibit |  | Description
10.1 |  | Letter to Greenhouse Funds LLLP dated August 19, 2022 (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 22, 2022 and incorporated herein by reference).
10.2 |  | Letter to Brown Advisory Incorporated dated August 19, 2022 (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 22, 2022 and incorporated herein by reference).
10.3 |  | Letter to Thrivent Asset Management, LLC dated September 30, 2022 (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 4, 2022 and incorporated herein by reference).
31.1 |  | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
31.2 |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
32.1 |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **
32.2 |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **
101.INS |  | XBRL Instance Document *
101.SCH |  | XBRL Taxonomy Extension Schema Document *
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document *
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document *
104 |  | Cover Page Interactive Data File – formatted as Inline XBRL and contained in Exhibit 101
* |  | Filed herewith
** |  | Furnished herewith

‎

41

CLARUS CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | CLARUS CORPORATION
Date: November 7, 2022 |  | By: | /s/ Warren B. Kanders
|  | Name: | Warren B. Kanders
|  | Title: | Executive Chairman
|  |  | (Principal Executive Officer)
Date: November 7, 2022 |  | By: | /s/ Michael J. Yates
|  | Name: | Michael J. Yates
|  | Title: | Chief Financial Officer
|  |  | (Principal Financial Officer and Principal Accounting Officer)

42